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A research group named “Snow” at Norwegian Center for Integrated Care and Telemedicine 
(NST) has developed a prototype of a Disease Query Engine that is capable of performing 
epidemiological searches. That feature coupled with interface for electronic consultation makes 
an interesting product “Erdusyk” that has good customer, societal and business utility.  The 
research group has a larger focus on academia and quite lesser motive for commercialization. In 
an attempt to assist the researchers in the commercialization process as well as to enhance 
entrepreneurial education through providing students with knowledge from both the academia 
and the industry, the idea was presented to a master’s degree student of Business Creation 
Entrepreneurship at UiT to find out a viable commercialization strategy. The viable 
commercialization strategy is presented in this master’s thesis.  
 
The research is guided by a main research question which is then divided into three sub-
questions for specificity. The main research question that is “development of feasible 
commercialization strategy for Erdusyk” goes through the process of innovation study, 
marketing study and business plan each guided by their own sub-question. The innovation study 
provides insights of the technicalities of the product and utilities it offers to the customers, 
society and the business world. It also identifies the type of innovation involved in the product. 
The degree of innovation involved in the product has implications on the market strategy. The 
market strategy is formed on the basis of the innovation study and information from a 
questionnaire survey, some semi-structured interviews and some secondary data. A market entry 
strategy is formed as a result. Similarly, closely linked to the innovation study and market study, 
a business plan is formulated. The business plan will provide the real world image of several 
players in the value chain and their interests. It will propose a business model that is suitable for 
the idea and the financial scenario that might follow with that model. Calculating a tentative 
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1.  Introduction 
 
Universities have for long been associated with their functions of educating and research. The 
two functions were considered the first two missions of the Universities. However, the concept 
of ‘service’ as the third mission has also been established lately. This mission of the university is 
more concerned with assisting in the economic development of the region the university is 
situated in. In excess to their traditional and primary focus on education and research, 
universities now also invest heavily in the creation of value for business and society (Curley & 
Formica, 2013). Following that notion, there has been a gradual shift in Universities’ focus 
towards commercializing research, licensing of technology, creating university spin-offs, 
introducing entrepreneurship programs, and expanding university-industry relations. Foss & 
Gibson, (2015) point out that, universities can become entrepreneurial in two ways; through 
academic entrepreneurship and through entrepreneurial education. First through academic 
entrepreneurship, universities strive for commercialization of knowledge and research often 
known as technology transfer. Second, through entrepreneurial education, universities build their 
entrepreneurial capability through the students, faculty members and researchers. According to 
Ambos et al. (2008), universities are demonstrating ambidexterity in their ability in producing 
both scientific knowledge and technology outputs and in being vital engines for economic 
growth by introducing the produced knowledge, innovations and technologies to the commercial 
market. 
 
UiT - The Arctic University of Norway links the academic entrepreneurship process with 
entrepreneurial education by providing students of entrepreneurship opportunity to work with 
academic entrepreneurial ideas. This master’s thesis is created by a final year master’s student of 
Business Creation and Entrepreneurship at UiT and is a case of an academic entrepreneurship. 
This paper strives to find out a feasible commercialization strategy for a technology developed at 
a university based research organization. It attempts to create a new potential business venture by 
transferring the theoretical knowledge originating from an academic environment, into 




The technology was developed at Norwegian Center for Integrated Care and Telemedicine 
(NST) which is a University based research organization in Tromsø. The technology developed 
at NST has, among others, opened up possibilities for disease query, electronic consultation with 
doctors and epidemiological search. The three possibilities are bundled up and offered as a 
package through the internet at https://www.erdusyk.no. The technology seems to provide some 
values to people by eliminating some of their problems and thus have a business potential. The 
business potential of the idea has been explored by a student of entrepreneurship manifesting the 
feasible customer group and a way to effectively introduce the idea into the market. For the 
convenience, the technology will be referred to as Erdusyk in this paper hereafter. 
 
1.1 Erdusyk within E-health 
With the introduction of information and communication technology, the health sector has 
dramatically changed. Currently, a significant share of disciplines of Medical Informatics 
address the usage of internet to provide health related services and information. Being an 
important aspect of current society, current healthcare system needs to be effective and efficient. 
Haux et al. (2002) point out that constant development of new technologies is critical for the 
health care system in order to comply with the rising global population. Information and 
Communication Technology is one of the key sectors that have the potential to improve the 
health care system to fulfill the increasing demand of improved health care system. When the 
electronic communication and information technology are incorporated within the health care 
sectors, the conjugation is commonly known as electronic health or simply e-health. Practice of 
e-health increases the efficiency of the health care services and also provides comprehensive 
information and support in decision-making process for health care providers as well as seekers. 
The use of e-health technologies has been, in many cases, known to reduce the administrative 
costs, make efficient use of medical resources and provide better collaboration across the 
different levels of the healthcare systems. One of the main objectives of e-Health lies within the 
support and relationship between patient and their healthcare providers.  
 
The thesis topic is to develop a feasible commercialization strategy for Erdusyk. Erdusyk is an e-
health innovation designed to assist health care seekers (patients) and providers (mainly doctors) 
in their pursuit and delivery of health care services. The main value of the innovation for patients 
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and doctors is in providing relevant information and knowledge about the disease and diagnosis 
for them to make decision regarding what to do next, in an attempt to eliminate the unnecessary 
transportations for physical consultation by substituting it with an electronic one if possible when 
people are ill. The invention was made at Norwegian Centre for Integrated Care and 
Telemedicine (NST), which is part of the University Hospital of North Norway (UNN). The 
project started more than a decade ago and the prototype of the innovation is available at 
https://www.erdusyk.com already. A research group known as “Snow” at NST was formed in 
2003 and it has been working with the project since 2007. The necessary infrastructures are 
mostly in place and the business value of the idea is noticeable. However, the research group had 
low commercialization motive as is the case with most of the researchers and other people from 
academia (Harding & Bosma, 2007).  
 
1.2 The Importance of the Topic 
Borges & Jacques Fillion (2013) point out that the resources that universities put at the disposal 
of researchers and academics have not been effective enough on its own to encourage that group 
of people to create spin-offs. That ineffectiveness was clearly visible in this case too as no 
commercialization endeavors were made for a technology that started about over a decade ago. 
According to Borges & Jacques Fillion (2013), the reason for the ineffectiveness is, among 
others, due to the lack of the necessary business networks. In other words there is a big gap 
between researchers and the business world. Foss et al. (2013) highlight the roles of 
entrepreneurship students in filling up the gap between the researchers and the business world. 
The fact that entrepreneurship students have academic education, the idea of the real world 
environment that a business has to live through and also greater degree of autonomy as compared 
to academia, makes them more likely to contribute in the commercialization than researchers. 
The third mission of a University is concerned with enhancing the rate commercialization of 
researches for economically assisting the region the university is embedded in. In an attempt for 
the successful recognition of the third mission of UiT, along with the academic entrepreneurship 
endeavors, entrepreneurial education was introduced. Norinnova Technology Transfer (NTT) is a 
technology transfer office for UiT and it provides different kinds of support to business ideas 
from providing incubation service for startups to finding investors and industry partners for 
them. It has an important role in the academic entrepreneurship process. Similarly, on the other 
4 
 
side, the master’s degree of Business Creation and Entrepreneurship was begun at UiT in 2009. 
Following the notion of the importance of students in bridging the gap, the entrepreneurial 
education program (BCE in this case) is expected to contribute highly to the academic 
entrepreneurship process. Under the same notion, BCE students are provided with the 
opportunity to write their master’s thesis on the commercialization of researches. The process is 
believed to develop academic entrepreneurship by enhancing the number of university spin-offs 
resulting from the works of the students from the education program.  
 
This thesis case is a part of that very endeavor of UiT. The research based potential business idea 
from NST was presented to the students of BCE by Norinnova Technology Transfer (NTT). 
Under the premise that entrepreneurship students are able to fill up the gap between the 
researchers and the business world, the students were provided the chance to work closely to the 
inventor together with the supervision from BCE faculty staffs and NTT. It is beneficial for both 
the entrepreneurial education as well as the academic entrepreneurship process. As such, the case 
ended up in the hands of the author of this thesis who is a final year student of master’s degree in 
BCE at UiT.  
 
1.3 Research Question 
The main objective of this case, as stated above, is to generate a commercialization strategy for a 
research based idea. According to Alänge & Lundqvist (2011), the commercialization process 
begins with development of technical and market information, and then identification of market 
opportunities and finally evaluation of the business potential. The steps provide a framework on 
how the thesis will proceed. To determine how feasible the technology is and to identify the 
unique value propositions, an innovation study is conducted. The insights from the study will 
inform about the values the customers receive from the product. It helps to evaluate the situation 
of use and potential customer segments. The market study is built on the knowledge from the 
innovation study, by developing a strategic tool for evaluating the feasible target market on the 
basis of market analysis. The findings from both the technical and market study will provide vital 
information in order to create a business plan.  
The research questions will provide guidelines on what the entire thesis and sections of the thesis 
will deal with. Bryman & Bell (2015) insist on breaking the research question into sub-questions 
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in order to serve as a guide for the study. The research question is thus divided into two parts viz, 
the main research question and sub-research questions. The main research question deals with 
the objective of the entire paper and the sub-questions dictate the focus of the sections of the 
thesis stated above. The main research question for this thesis is:  
 
What is the viable way to successfully commercialize Erdusyk in Norway? 
 
The sub-question for the innovation study is:  
What is the innovation level of Erdusyk and what value propositions does it provide to the 
potential users? 
 
The question is answered in the Innovation study chapter where the current prototype of Erdusyk 
and the technology behind it is discussed. The level of innovation involved and the impact of that 
on the next steps of commercialization process is evaluated. 
 
The sub-question for the marketing study is: 
Is there a real market potential for Erdusyk and which market strategy will lead to successful 
commercialization? 
 
The market study will deal with the evaluation of market structure. That is a task consisting of 
garnering information about the potential customers, targeting them and finding out way to 
effectively reach up to them. This will all be vital information for establishing a marketing 
strategy for Erdusyk. 
 
The sub-question for business plan is: 
What is the development strategy for successfully starting the business and operating the entire 
value chain process? 
 
The business plan will illustrate the risks, rewards, market strategy, action plans, financial 
evaluation and an investment proposal for the business based on information on the two 





This study is mainly based on a qualitative method. The analysis of potential customers however 
was based on a quantitative approach. Thus, the study made use of both the qualitative tools and 
the quantitative tools.  
 
According to Cresswell (2003), qualitative research is built upon the multiple interpretations of 
individual’s experiences that are socially and historically constructed and have the ability to 
develop a theory or a pattern. Quantitative research, however, is more based on cause and effect 
and has pre-specified variables and hypotheses that are tested. Mixed methods make use of both 
qualitative and quantitative techniques and are more consequence-oriented and problem-centered 
and have pluralistic implications.  
 
According to Colin (2002), qualitative methods are often chosen when the focus of research is on 
the process rather than the outcome. It provides enlightenment, understanding and extrapolation 
of the situations and is much suitable in understanding a certain phenomenon. Qualitative 
research includes observations, interviews, content analysis of documents, case studies, articles, 
books, in addition to descriptive statistics such as census data (Strauss & Corbin, 1990). 
Quantitative research is more of a fixed design as there needs to be a concrete pre-specification 
before the data collection is done (Colin, 2002). The pre-specified hypotheses are either verified 
or falsified by the findings. Quantitative research involves experiments and surveys and 
statistical processing. It makes use of different measurement techniques such as questionnaires, 
time studies, tracking of outcome, and a broad range of more or less rigorous designs such as 
randomized controlled trials, meta-analysis, cohort, case control and observational studies.  
 
In a mixed design, both quantitative and qualitative techniques are used. Usage of both 
quantitative and qualitative methods provides improves validity and reliability of research which 
is also known as triangulation (Quinlan, 2011). By this method, the results of quantitative 
method can be checked against that of qualitative method and vice versa. In a mixed design, 
usually a hypothesis is created from qualitative method which is then tested using the 
quantitative method (Colin, 2002). Qualitative research provides rich description of the context 
and the processes while the quantitative method provides an account of the outcomes of the 
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research. The conglomeration of the two provides the account of the process as well as the 
objective truth. This thesis case makes use of both qualitative and quantitative techniques of data 
collection. The research follows a mixed method in that sense. However there is "minimal 
integration" between the two where there are separate results sections for each method, and only 
a brief discussion of their mutual implications. Questionnaire survey, qualitative interviews, 
observation and secondary data were used for the study.   
 
In the early phase of the study, data were collected using interviews, informal discussions and 
several meetings with the leader of the inventor group. The initial meetings dwelled around the 
issues of understanding the innovation itself. Notes were taken for the documentation. The 
technology being heavily relied upon the consent of doctors, need to solicit information from 
doctors was evident. Five doctors were approached out of which three agreed for interviews. 
Semi-structured interviews were conducted ranging from 20 minutes to 40 minutes. Two of the 
interviews were tape-recorded while only notes were taken for one. More than ten meetings were 
done with the inventor during the period. Notes were taken from every single meeting. Similarly, 
nine meetings were done with the supervisors of various parts of the thesis.  
 
Similarly, a questionnaire was prepared to carry out a market survey as a part of thesis (refer to 
appendix 1). There was very little information on the people’s attitude towards the healthcare 
service from the perspective that was relevant for this case. To elicit that information, people’s 
response about the healthcare system in Norway was needed. The questionnaire was created in 
English language. 145 people participated in the survey. Convenience sampling method was used 
mainly due to the resource of study. Time and financial resource for the study was quite limited 
and thus limiting the data collection to convenient sample only. The research was based in 
Tromsø. Most of the data collection took place online through distribution of questionnaire by 
friends and colleagues. The responses were especially important for the marketing study part. 
The questionnaire and the responses are available in the appendix. Use of secondary data was 
much relevant for generating knowledge about the competitive scenario, some statistical data, 




1.4.1 Innovation Study  
The purpose of the Innovation study is to investigate the technology in order to identify customer 
utilities and its commercial potential and to place it within an innovation framework. The 
development stage that the technology is in and the degree of innovativeness involved in the 
technology has important role in the marketing plan and next steps.  
 
The innovation study will make use of Alänge & Lundqvist’s (2014) idea evaluation framework. 
According to Alänge & Lundqvist’s (2014), the idea evaluation process identifies and expresses 
the potentials of the idea and makes it more likely to gain momentum and attract more resources 
in the commercialization process. The idea evaluation focuses on the creative packaging and 
communication of the idea. The packaging attracts future and many yet to be identified 
stakeholders towards the idea and help to bring the idea forward. The packaging concept makes 
ideas attractive and gives ideas new destinations, inspiring new settings and new people.  
 
Alänge & Lundqvist’s (2014) idea evaluation process consists of four sections; a summary, an 
idea description, value visions and next steps. First, the summary part will primarily frame the 
essence of the idea and its potential future value in as attractive way as possible. The motive 
behind this is to capture the attention of reader and get them to read further. An idea description 
will try to capture the idea and its setting. It often includes a technical description, a novelty and 
freedom to operate (FTO) analysis and the presentation of the idea provider. Value visions 
present the specified situations of use and identification of customer, societal and business 
utilities. Finally the next steps involve indicating market potential and needs of further 
development and verification, and some financial estimation. 
 
After the idea evaluation for the technology is done, the next step is to determine the 
innovativeness involved in the innovation. As Kassicieh et al. (2002) state, different innovation 
types require different marketing and business orientations. Thus it is imperative to find out the 
degree of innovativeness involved in the product. This section will follow a framework of Garcia 
& Calantone (2002) as well as that of Thomond, Herzberg & Lettice (2003) and Dosi (1982) to 




According to Garcia & Calantone (2002), radical innovations have been defined as innovations 
that embody a new technology that results  in a new market infrastructure and results in 
discontinuities on both industry or market level (macro level) and firm and customer level (micro 
level). Incremental innovations cause a marketing and/or technological discontinuity on micro 
level but not on macro level. Really new innovations consist of the largest frequency of 
innovation and cover the combinations in between these two extremes except the discontinuity in 
both marketing and technology in macro level.   
 
From another perspective, Thomond, Herzberg & Lettice (2003) posit that disruptive innovations 
allow organizations to transfer the demand and needs of markets. The innovations that do not 
cause the market discontinuity are sustaining innovations. Similarly, Dosi (1982) posits that 
radical innovations break the continuity of existing technological paradigms and set the stage for 
new technological trajectories. The innovations that do not cause technological discontinuity are 
incremental.  
 
This section of determination of innovativeness makes use of a conglomerated framework of 
Garcia and Calantone (2002), Thomond, Herzberg & Lettice (2003) and Dosi (1982) to evaluate 
the innovativeness and classify the innovation. The idea evaluation and the innovation 
classification provide the context for the innovation to explore marketing implications and 
develop marketing strategies.   
 
1.4.2 Market Study 
The market study builds on to the findings of Innovation study. Different types of business ideas 
that have different types of innovations involved require different marketing orientations. For 
evaluating a suitable marketing strategy, the concept of revised technology adoption life cycle 
proposed by Moore (2014) is considered.  
 
When a new disruptive target enters the market, it follows a certain pattern of adoption by the 
customers. The technology adoption life cycle model have, for long, believed to consist of a 
smooth bell curve having customers of high-tech products, progressing from Innovators, Early 
Adopters, Early Majority, Late Majority, and Laggards. Moore (2014) has revised the old curve 
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with a new model that has cracks between the customer groups. The largest crack is between the 
early adopters and early Majority which he refers to as “the chasm”. The cracks denote the 
difference in attitude and preferences of the different groups and the inertia to accept the new 
technology. The chasm denotes the huge difference in the acceptance of new technology between 
the early adopters and early majority.  
 
It is believed that early adopters are enthusiasts and that many firms might somehow be able to 
get the enthusiasts buy the product. However, they are quite less in number and the true dollars 
lie in the early majority group which consists of people who are more pragmatic. For successful 
commercialization, there is a need to cross the chasm and that is where many companies fail. 
Providing a D-day analogy, Moore (2014) suggests that to successfully cross the chasm, firm 
should focus on a single market segment, dominate over it and then attack the adjacent segments.  
 
For the development of market strategy, customer analysis, competitor analysis, market analysis 
and environmental analysis are performed in that sequence. Market strategy is developed based 
on the analyses. Customer and competitor analysis and market analysis are developed from the 
data from questionnaire survey, interviews and secondary data. Environmental analysis will use 
PEST analysis to evaluate the political, economic, social and technological environment. 
Similarly, to identify the internal strengths and weaknesses as well as the opportunities and 
threats presented by the environment, SWOT analysis is conducted.  
 
Marketing strategy is developed using marketing mix strategies. The marketing mix can be 
defined as the set of tactical marketing tools that the firm blends to produce the response it wants 
in the target market (Kotler & Armstrong, 2013). It consists of 4Ps namely, product, price, place 
and promotion. Following the notion, strategies for product, pricing, distribution and promotion 
are developed to achieve the marketing goals.  
 
1.4.3 Business Plan 
It has been widely believed that the sole purpose of a business plan is to persuade investors to 
invest in the new business. However, even before that, business plans enlighten entrepreneurs so 
that they realize future problems and risks in advance and be ready to adjust to the problems as 
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they occur. The business plan is a paper where the future plans and future company itself are 
written down. According to Hormozi, Sutton, McMinn, & Lucio (2002), describing the company 
on paper provides an opportunity to identify problems and propose solutions without real world 
consequences. 
 
Despite the benefits for the entrepreneurs, the business plan is usually prepared for the outsiders 
especially the potential investors. The structure and content of business plan varies according to 
the external readers and their motives. In this case, the business plan builds upon the findings 
from innovation study and market study. The business plan is thus constructed on the context 
that is established by the technical and market study. The thesis ends with the business plan. 
 
There are many structures for business plans available and they serve different purposes. The 
framework of the business plan used here is a customization of plurality of business plans 
available in the internet and the one illustrated by business plan supervisor. The business plan 
begins with an executive summary that includes background information, the values and the 
market potential. Next it will go on to describe the problem and then the solution offered in 
detail. After that the value propositions for different value chain members are illustrated. After 
that, the entrepreneurial team and the members are introduced. The market potential is then 
explored and the competitors identified. Then the business model is presented that describes the 
entire value chain activities. After proposing the market entry strategies, it will lay out the 
important milestones for the future. That is followed by financial estimation and company 
valuation. Finally, the critical risks are analyzed and the exit strategy is identified.  
 
The business plan is prepared in a way to appeal equity investors in investing in the company. It 
acts thus as a stand-alone document in itself. However, it also serves as an operational plan for 
moving the idea on through the commercialization process. It creates a roadmap for the steps to 
be followed while proceeding with the further commercialization process.  
 
1.5 Limitations 
There are some limitations to the thesis. Firstly, the availability of just a semester’s time for the 
study is a limitation. This seriously limits the extent of information that can be gathered and 
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studied. From few interviews with doctors, it seemed like the whole plan was falling apart 
because doctors would not approve the product due to problem with their remuneration as 
defined by the law. Later on it was found out that there was a way to work around the issue and 
that would not cause any problem for the doctor’s income. However, the deadline had already 
approached and there was no time to talk to other doctors and include the response modifying the 
work already done by then. The limitation of time and the complexity of the idea warranted 
drilling down the idea for a narrow focus for the master’s thesis. That left out some of the 
important features of the invention that would appeal different sets of users in different ways 
making the product more complete.  
 
The data collection methods included questionnaires, semi-structured interviews, observation 
and secondary data. The primary data usually consist of sampling and respondent errors. The 
sample for questionnaire survey was chosen using a convenience sampling method. The survey 
was done mainly on people living in Tromsø. Also, the respondents were approached through 
networks of friends, colleagues and acquaintances. The use of convenience sampling might have 
infiltrated some degree of bias in the data collected which have not been considered in the case. 
Similarly there is a chance that some respondents may have been reluctant to provide the true 
information or in some cases make unintentional errors due to, among others, not understanding 
the question given. Also interviewer might have made some mistakes during interviews due to 
various reasons such as not being trained in performing field studies and qualitative research. 
The size and scope of the data collected is thus not free of limitations. That being the case, the 
responses that led to the decisions about the product being favorable for the common people and 
their willingness to pay for it imply the assumptions that people are really willing to pay for it. 
That is an expression of interest from the customers and it cannot be known for sure whether or 
not customers will really pay for it unless the product is really out there in the market.  
 
Similarly, it proved really difficult to get to connect to doctors and receive information from 
them most probably due to lack of contacts and networks. It was only possible to collect 
information from three doctors. Most of the secondary information were available in Norwegian 
Language and thus were difficult to interpret. Similarly, no data were available on some of the 
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issues especially in market study and financial estimation part. That led to the need of 
assumptions for the cases.  
 
The author of the master thesis is a student from the academic side of the business. The product 
is a telemedicine device that is a combination of Information Technology and Health Care 
system. As such the knowledge of the technicality of the product is mostly dependent upon the 
knowledge provided by the inventor and publications made in the field. Thus, the thesis might 
not be able to sufficiently explain the product from technical point of view.   
 
1.6 Conclusion 
This main objective of the thesis topic is to find out a suitable commercialization strategy for a 
research based telemedicine product Erdusyk. The main research question is formulated as per 
the objective. The question is further divided into three sub-questions in order to provide the 
comprehensiveness to the question. Using both the qualitative and quantitative research methods, 
the paper answers the questions. The paper begins by defining the innovation, its values, the 
market, and the industry the innovation will compete in. Based on the information from the 
initial section, market study is conducted. Data on market study were gathered from a 
questionnaire survey, semi-structured interviews and secondary data. Finally, the business plan 
on how to actually enter the market is proposed based on the market study and innovation study. 
The three sections are interrelated and collectively propose a strategy for moving the innovation 
forward and entering the market.  
 
The innovation study is carried out based on the idea evaluation model of Alänge & Lundqvist’s 
(2014). The sub-research question of finding out the innovation level of Erdusyk and the value 
propositions for potential users is answered using the innovation classification proposed by 
Garcia & Calantone (2002) and by Thomond, Herzberg & Lettice (2003) and Dosi (1982). In 
response to the sub-question for the section, the innovation was categorized as a really new 
innovation and as an Incremental-Disruptive based on the framework of Garcia & Calantone 
(2002) and of Thomond, Herzberg & Lettice (2003) and Dosi (1982) respectively. It spares 
patients of the difficulty of travelling to doctor’s office when ill, and fulfills their need for 
epidemiological information about disease. Many people do not like to waste a lot of time at 
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clinics, wait in the queue, and perform physical transportation when they are unwell. By 
substituting unwarranted physical consultations by electronic ones, it eliminates the problems 
thus creating the customer value. Similarly, it has some values for the society as well such that 
people might be able to detect epidemics early and thus treat them early. That might lower the 
health expenses for government and better health security of local people. Similarly, the idea has 
a business value so as to develop monetary benefits for investors. Though, the idea will need 
substantial investment in initial few years, it has a potential for significant income in the future 
creating a good prospect for investors to invest their money in.  
The sub-research question for the market study was whether there was a real market potential for 
Erdusyk and which market strategy will lead to successful commercialization. Based on the 
results from the questionnaire survey, a significant proportion of people are found willing to try 
the service out and pay for the technology. Out 145 respondents, 112 were willing to try 
electronic-consultation and 89 said they were ready to pay. Also, 63% of respondents were 
interested in knowing whether other people had similar problems at that particular point of time 
when they were sick. The statistics shows that people are willing to try the product thus proving 
the market potential. The market entry strategy is influenced by the innovation type the 
innovation represents. Moore’s (2014) idea of crossing the chasm is used in selection of the 
target customers. Handicapped and Chronic patients will be the initial target customers for the 
idea. After the competitive scenario evaluation, PEST and SWOT analysis are used for the 
environmental analysis. The economic status of Norwegian population is well off to use the 
product and the technological aspect is equally as favorable. Though there are some skeptics, the 
social context is favorable too. The rule regarding the salary of doctors is one of the ingredients 
in political environment that negatively affects the idea though there are ways to work around the 
rule. Hence, real market potential was found to exist and that chronic and handicapped people 
should be targeted as a target group for safer market entry.  
 
The business plan employed here is a customization of many different frameworks available. 
Overall, it consists of the problem and the solution, value propositions, the team, market forces, 
business model, market strategy, action plans, financial evaluation, risk analysis and an exit 
strategy for the proposed business. It was found out that the doctors are the important members 
of value chain and thus there is a need to make collaboration with them. The product is offered to 
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patients as a subscription or as a stand-alone product. People pay for the service charge in excess 
to the normal consultation fee that they pay to the doctors. The technology was devised by the 
research institute based in Tromsø and has already begun the infrastructure installation process in 
Tromsø. Due to the geographical proximity, existing networks, and significant population, 
Service will be first offered in Tromsø. The service will then be offered in Troms and Finnmark 
and then in Oslo followed by the counties with highest population. The service will be developed 
full-fledged in five year’s time. The company has a significant business value but lacks sufficient 
capital to start and run for first few years where the cash flow is negative. For the company to 
stay cash positive and make necessary investments for the infrastructures in the initial years, 
capital is needed. The investment capital of 15 million is summoned in exchange for 30 % 

























2. Innovation Study 
 
The aim of this chapter is to present and analyze the technical aspects of the invention. This 
chapter is guided by the following sub-research question “What is the innovation level of 
Erdusyk and what value propositions does it provide to the potential users?” Following the idea 
evaluation model of Alänge & Lundqvist (2014), this chapter describes the technical details of 
Erdusyk and discusses the values it will provide to the market. After that, assessment of the 
utility potential as well as discovery of the innovativeness of the invention is done. First, the 
description of Erdusyk provides insights into its functional capabilities and technical 
characteristics. Then the utilities of the innovation are discussed. The technical description and 
the utilities will provide provide information on the nature of innovation involved.  Finally, the 
innovation is positioned on a scale of innovativeness based on its significant attributes.  
 
2.1 Innovation Theory 
“Innovation is an iterative process initiated by the perception of a new market and/or new service 
opportunity for a technology based invention which leads to development, production, and 
marketing tasks striving for the commercial success of the invention” (OECD, 1991). According 
to Garcia & Calantone (2002), this definition addresses two important distinctions: 1) the 
‘innovation’ process comprises both the technological development of an invention and the 
market introduction of that invention to end-users through adoption and diffusion, and 2) the 
innovation process is iterative in nature and thus, includes the first introduction of a new 
innovation and the reintroduction of an improved innovation. 
 
There has been a large amount of research on innovation and as much number of innovation 
typologies has been introduced. Radical, incremental, disruptive, sustaining, revolutionary, 
continuous, discontinuous, imitative are some of the typologies used in the research that have 
often created confusion in the innovation literature. Due to the different constructs used by 
different researchers, inconsistencies often take place while comparing firms. Garcia & 
Calantone (2002) have made it easier by associating the forms of innovation with correct 
typologies. They categorize the innovation types as radical, really new, discontinuous, 
incremental and imitative.  
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Radical innovations have been defined as innovations that embody a new technology that results  
in a new market infrastructure and results in discontinuities on both industry or market level 
(macro level) and firm and customer level (micro level). Radical innovations often do not 
address a recognized demand but instead create a demand previously unrecognized by the 
consumer. This new demand cultivates new industries with new competitors, firms, distribution 
channels, and new marketing activities. According to Garcia & Calantone (2002), radical 
innovations are innovations that cause marketing and technological discontinuities on both 
macro and micro-level. In contrast, incremental innovations cause a marketing and/or 
technological discontinuity on micro level but not on macro level. Really new innovations consist 
of the largest frequency of innovation and cover the combinations in between these two extremes 
except the discontinuity in both marketing and technology in macro level. Discontinuous 
innovations refer to the innovations that cause discontinuity in the technology irrespective of the 
market (O'Connor, 1998; Tushman & Anderson, 1986). So, a discontinuous innovation can yet 
be a radical or a really new innovation based on whether the technological discontinuity is 
caused at macro or micro level together with the position of market discontinuity. Finally, 
imitative innovations are those innovations that rival the innovation of the first company to 
develop R&D and successfully commercialize it. These are usually incremental innovations and 
rarely really new (Garcia & Calantone, 2002). The invention will be evaluated based on these 
classifications. 
 
2.2 The Invention “Erdusyk?” 
Erdusyk.no is primarily a disease query engine (DQE) with epidemiological search equipped 
with a platform for e-consultation. The invention was done by a research group called Snow at 
Norwegian center for Integrated Care and Telemedicine (NST), Tromsø, Norway. The disease 
query engine (DQE) provides people with a search engine where people enter their symptoms 
and get suggestions on possible disease they might have caught. The general concept behind this 
service is to provide people who get ill with relevant and quality information in order to assist in 
decision making regarding the treatment of illness and the doctor’s visit. It makes use of the 
epidemiological database for retrieval of information of diseases based on symptoms elicited by 
patients and provides facility for e-consultation for the people who need it. The epidemiology 
contains information from patient’s EHR (electronic health records) at General Physician’s 
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offices, from search hits at DQE itself and from Lab Information System at Microbiology labs. 
The e-consultation will be in the form of text, audio or video interaction between the doctor and 
the patient. Currently it is a website and will also be designed as a phone application. ‘Er du 
syk?’ means ‘are you ill?’ in Norwegian and for now the DQE is targeted for the Norwegian 
market. The product is available at https://www.erdusyk.no. The invention has following 
features; 
 
2.2.1 Disease Query Engine 
Disease query engine as the name implies is a search engine that serves for disease detection. 
Disease Query Engine, often abbreviated as DQE, matches the sets of symptoms elicited by the 
users to the disease information stored in a database and informs the possible disease caught by 
the user with that set of symptoms.   
 
Bellika, Marco & Wynn (2014) have developed a prototype of a disease query engine (DQE), 
that matches symptom sets (technically known as query vector) to diseases (technically known as 
disease vectors) based on the daily updated data about communicable diseases in some of the 
municipalities of Nordland, Troms and Finnmark counties in Northern Norway. The prototype of 
the DQE is available at Erdusyk.no. Using Bayes’ theorem, the DQE calculates the disease 
likelihood based on the symptoms set and disease vectors (see appendix for Bayes’ theorem).  
 
2.2.2 Electronic Consultation 
Commonly an electronic consultation is the process of using the internet to ask the public their 
opinion on one or more specific topics while also allowing for discussion between participants 
(E-consultation.org). In telemedicine process, e-consult refers to a mechanism that helps primary 
care providers (PCPs) to obtain specialist’s inputs for a care treatment of patients eliminating the 
need for the patients to have a face-to-face visit. 
 
However, the scope of e-consultation extends more than the interaction between primary care 
providers and the specialists. In this case the use of e-consultation is being proposed for the 
primary care the patients receive from their general physician (GP). Erdusyk will, in addition to 
the Disease Query Engine, provide infrastructure for e-consultation with the GP. The 
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consultation can be in the form of text, audio or video form. It will supposedly spare patients 
with the hassle of having to physically travel to doctors since it is especially inconvenient to do 
that when they are sick. 
 
2.2.3 Epidemiological Model 
According to Porta et al. (2014), epidemiology refers to the study of the distribution and 
determinants of health-related states or events in specified population, and the application of this 
study to the control of health problems. Erdusyk provides, to users, medical information relevant 
to their disease search based on the distribution of similar problems in specific population group 
in specific geographical area. For example, if somebody shows symptoms of a particular flu, 
then Erdusyk will detect the population that have reported with similar problem and the 
preventive measures taken by them. That way, several communicable diseases can be detected 
early and also users will have access to medical information that assist in decision making 
related to the treatment. The epidemiological model makes a huge impact on the disease 
diagnosis process and thus is an important part of the disease query engine.  
 
2.3 Technology Underlying the Invention 
2.3.1 Mini Computer (Appliance Box) 
For the possibility of existence of disease query engine based on epidemiological model with e-
consultation, there is a need to set up an infrastructure that links all the doctors and microbiology 
labs and the users. The infrastructure needs to be such that it collects epidemiological data from 
all the health institutions, does the statistical processing and creates epidemiological information 
regularly. Also, the infrastructure needs to be able to create contact between patients and doctors 
for e-consultation. To do all that, minicomputers (often known as appliance box) containing 
special software as well as virtual ones is used.  
 
The minicomputer (or the appliance box) is basically a barebone, small form factor Personal 
Computer. It is basically a computer. It is pretty small, about the size of an external hard drive, 
although some are even smaller. Despite its size, it has as much power and capability as a regular 
desktop. The computer only comes with the case, motherboard, and the CPU. Everything else 
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All the Software that are responsible for doing the actual work will be pre installed in the 
appliance boxes. The boxes are then shipped to the GP offices and health institutions. The GP 
offices and other health institutions have to plug the device into their Information Technology 
system. The more health institutions set up the device, the better is the epidemiological 
information and disease query engine and larger is the scale of e-consultation. The target is to set 
up the boxes in as many institutions as possible. Once the device is plugged into the system, it 
will automatically start to extract the necessary information and generate epidemiological 
information. There are two software installed in the appliance box viz. Snow and Emnet. Snow is 
clinical informatics software created by SNOW research group at NST. It performs tasks of 
extracting information from the local server at GP offices and health institutions, storing the 
epidemiological information on appliance boxes and coordinating the computations across 
appliance boxes from many health institutions. Similarly, Emnet is statistical processing software 
that performs the statistical calculations to yield the epidemiological information.   
 
2.3.2 Technical Architecture 
The technical architecture of the process of data extraction and use for the creation of 
epidemiology and the functioning of disease query engine is depicted hereby; 
 





The figure above shows a GP office, a microbiology lab, the internet and the health net separated 
from one another by firewalls. Appliance boxes with snow server are installed in both the GP 
office and the lab. Snow server inside the appliance box extracts data from the Electronic Health 
Records (EHR) in GP offices and from the Lab Information System (LIS) in microbiology labs. 
The data from GP offices provides statistics about disease diagnosis while that from lab provides 
statistics of disease agents (eg. bacteria, virus, etc.). Similarly, the disease queries made by 
people through the disease query engine provide the statistics of symptoms from general public. 
The combination of the three statistics forms epidemiological information at health net server. 
That epidemiological information about disease diagnosis, disease agent and the disease 
symptoms are provided to the users who perform the disease search through the disease query 
engine. Similarly, for the e-consultation, people send in their symptoms as well as 
epidemiological information to doctor and get back diagnostic information. Every individual 
diagnostic case, irrespective of whether or not it is an e-consultation, is documented and stored 
as EHR by doctor. Similarly, the microbiology lab stores information of disease agents for every 
microbiology sample taken from patients. The epidemiological information computed by health 
net server is updated with increasing number of cases.  




Thus, when someone puts in a disease query through Erdusyk.no, the disease query engine 
automatically searches the updated epidemiological information from previous symptom 
searches, disease agent statistics and disease diagnosis statistics and provides the information on 
how many other people performed search with similar problems, what actions did they take and 
the most possible diagnosis for the set of symptoms.   
 
2.3.3 The Graphic Interface 
The home page of Erdusyk consists of a panel on the top that gives information about Erdusyk 
and directs to the page for health personnel. The main body consists of tabs that help to create a 
new disease search or to retrieve a disease search done by the user in the past. The home page 
looks like as follows; 
 
 
The first figure above is the home page. The symptom checking page, the second figure, consists 
of a list of many symptoms related to different parts of the body. Users choose, from the list of 
symptoms, the symptoms that they are experiencing. After confirming the date and the place of 
the occurrence of the symptoms, the page with the confirmation of registry appears. The page 
consists of a snow reference code and a pin code so as to trace the search history by the same 
user. There is an option to receive the code through SMS or print out the page. The page consists 
of the symptoms searched for, the information put in, the disease predictions and the 
epidemiological information about the disease. The confirmation page looks like the last figure 
above. 
Figure 3: Erdusyk pages 
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2.4 Limitation of Invention 
The main drawback of the innovation is the need to collaborate with the doctors and other 
healthcare institutions. The appliance boxes need to be set up in healthcare institutions for the 
production of epidemiological information and for e-consultation. Similarly, there’s a need to set 
up as many boxes as possible for better epidemiological results and substantial market. The 
entire idea is dependent upon the consent of those institutions. They own the data that is required 
for the creation of epidemiology. Whether or not they want to provide the data is a serious 
question. Also, a question of trust arises such that the healthcare institutions need to trust the firm 
so as to allow it to connect the appliance box to their information technology system and extract 
data from it.   
 
The service needs internet connection for the users to be able to use the product. The technical 
architecture puts the data as close to the owners (GP offices) as possible. Unlike a single server 
for entire data, this method is much safer but it requires the use of the data extraction and 
processing tool at every data source. That makes it necessary to install the computer boxes at 
every healthcare institution.  
 
2.5 Intellectual Property Protection 
Software is non-patentable in Norway. Erdusyk needs a domain name protection as it is a web-
based product to be available under the same name. Design rights protect the design of any 
aspect of the shape or functional elements of design or configuration. Design protection is 
obtained automatically as soon as the design is published and thus there is no need to register the 
design (Davis, 2008). Another option for the structural control is trademark. Trademark is 
usually a sign that indicates the origin of goods or services that it is assigned to. It is quite 
valuable for quality as it provides competitive advantage and differentiation for the company 
(Davis, 2008). Trademark contributes significantly to the product differentiation for Erdusyk and 
strengthens the company values. 
 
2.6 Current Status of the Technology and Next Steps 
Currently, the Disease Query Engine contains the disease vectors for respiratory and gastro-
intestinal diseases. There is a need to create the disease vectors for all the existing diseases and 
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link the symptom sets to the vectors. There is a need to debug the software with every change 
made to ensure that it is free of problems. Similarly, the computer boxes have already been set 
up in some of the GP offices in Tromsø and Finnmark. The next step is to try to set up the boxes 
in as many GP offices as possible throughout Norway.  
 
2.7 Value Visions  
According to Alänge & Lundqvist (2014), identification of customer, societal and business 
utilities is an important step towards determining the value visions of a technology for its 
different situations of use. The utilities of a technology from the three perspectives set the overall 
value of the technology. The three utilities of the technology are discussed hereby. 
 
2.7.1 Customer Utility 
People may have considerable difficulty in travelling to doctor’s office when ill. Many times, 
people have to travel to the doctor’s clinic for meetings just to get little information or for 
follow-ups that can be done through telephone or an email or through video conferencing. Many 
people do not like to waste a lot of time at clinics, wait in the queue, and perform physical 
transportation when they are unwell. It is not always necessary to visit the doctor physically for 
minor disease confirmations, referrals, sick leave, medicine prescription and the likes. The pain 
is even larger for handicapped people and chronic patients because they have considerable 
difficulty in movement and that is even more so when they are sick.  This pain is alleviated by 
the e-consultation service. The chance of transmission of diseases from people to people at 
hospital’s lobby is decreased as well. Similarly, when people get sick, they want to know 
whether other people are having similar problem or not, and what measures are they taking. That 
information is much helpful for people when they develop some symptoms for the first time and 
want to know how they got it and what to expect from it. That way they can take some 
immediate decisions on their case; from what remedies to take to whether or not to see the doctor 
right away. 
 
The epidemiological information provides GPs with diagnostic decision support system which is 
quite important for doctors. It also disseminates procedural information among doctors which are 
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are of significant value to doctors. Also, the chances of disease transmission are lowered from 
patients to doctors.  
 
2.7.2 Societal Utility 
The installation of box and extraction of epidemiological information could help create disease 
surveillance system and epidemic outbreak detection system so that major epidemic outbreaks 
could be detected timely and preventive measures could be taken. This way the impact of huge 
epidemics could be mitigated and in some cases even avoided. That would mean lower health 
expenses for government and better health security of local people. People have better medical 
information at their disposal. The epidemiological information is useful for many research 
organizations that are working in philanthropic directions concerning people’s health. It also 
decreases wastage of resources in healthcare activities that can be done economically; for 
example an electronic consultation in place of a physical consultation. The commercialization of 
a telemedicine research, leads to creation of funds for further research in improving healthcare. 
 
2.7.3 Business Utility 
The invention has been seen to have utility for customers. The market study showed that people 
have difficulty travelling to doctor’s office when sick and are willing to try e-consultation and 
also want to know whether other people have similar problem or not (see market study section 
3.2.1). People are also willing to pay for it and have the technology required to do so. The 
Disease Query Engine and epidemiological data extraction and computation infrastructures are 
already developed. The programs have been installed in appliance boxes and tested. The idea has 
a business potential and ability to create value for investors. The business utility is 
comprehensively explained in the business plan section 4 below.  
 
2.8 Competing Technologies 
This section compares the needs of the people and the competitive offerings made in the market.  
Based on the study, there is no other technology around the globe that provides the combined 
service of health information, disease query engine and e-consultation. There are some world 
leaders in medical information providers in the competitive scenario such as mayoclinic, webmd 
and drugs.com but they do not offer epidemiological information for the disease query. None of 
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the disease query engine provides epidemiological search. The epidemiological information that 
Erdusyk.no has is unprecedented and it is updated in daily basis that makes it quite useful and 
makes the diagnosis more meaningful. Also, there is no service that provides e-consultation in 
the form of text, audio and video with the personal GP. Some of the GP offices have telephone 
query facility but that is not too appreciated by doctors. Some of the websites provide the facility 
only in the form of text. The consultation that they provide is not with the personal GP that 
makes it even undesirable. Helsenorge.no is one online health service provider that provides 
information on booking appointments, receiving prescriptions, conducting an e-consultation and 
having contact with the GP office if the GP provides such facilities and has made the information 
available at helsenorge.no. Under Helsenorge.no, the government is trying to build a central 
database called ‘kjernejournal’ that stores every person’s health records in a single server. 
However, that approach is vulnerable to misuse and might jeopardize the security of people’s 
private information. It needs doctors to store every patient’s information in the server per every 
consultation. Similarly, storing in a single server needs some encryption of data and it is not 
possible to reuse the data for other purposes in the future.  
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As shown in the figure above, none of the firms provide the entirety of services as Erdusyk. 
Conclusively, it can be said that the offerings made by Erdusyk is quite original and the 
competition is quite weak. No other firm is offering the entirety of service that erdusyk is 
offering. In that respect, Erdusyk is more of a first mover and can enjoy the significant market 
occupancy and technological leadership if successful.  
 
2.9 Positioning of the Innovation  
Not all innovations are of similar nature and intensity. Some innovations are quite shallow and 
are just marginal improvements to existing technology/market while others are rather radical and 
develop new technologies and markets much different than the existing ones (Garcia & 
Calantone, 2002). The different innovations have different impact on the market and the industry 
and are perceived differently by the customers. So, there is a need to build different 
infrastructures for successful commercialization of these innovations. That demands for different 
actions and orientations. Consequently, there is a need to follow different strategies for 
commercialization of different innovation types (Kassicieh et al., 2002). This section attempts to 
determine the type of innovation involved in Erdusyk. This will help to further identify the 
challenges and opportunities in the market involved with the product.  
 
According to Thomond, Herzberg, & Lettice (2003), disruptive innovations allow organizations 
to transfer the demand and needs of markets. So, disruptiveness depicts the degree of market 
discontinuity. According to Dosi (1982), radical innovation breaks the continuity of existing 
technological paradigms and sets the stage for new technological trajectories. So, the measure of 
how radical an innovation is, in this perspective, the degree of technological discontinuity. 
Following this construct innovations are classified as radical or incremental based on the 
discontinuity brought by the innovation on technology or knowledge and as sustaining and 
disruptive based on the discontinuity brought on the market. That way an innovation typology 
matrix was created classifying the innovation as radical-disruptive for high discontinuity in both 
technology and market, radical-sustaining for high discontinuity in technology but low in market, 
incremental-disruptive for low discontinuity in technology but high in market and finally 




The above architecture could, however, be included within the classification of Garcia & 
Calantone (2002) as described in section 2.1. The radical-sustaining in this case is quite similar 
to the radical innovation illustrated in the above paragraph since it depicts higher degree of 
discontinuity in both technology and market. Similarly the incremental-sustaining mentioned 
here is similar to incremental innovation above since the discontinuity is quite low in both the 
cases. Finally, the other two radical-sustaining and incremental-disruptive are similar to really 
new innovations discussed above since there is discontinuity in only one of market or technology 
component.  
 
The technology that the appliance box uses for performing the disease query and the 
epidemiological computation is quite innovative. But the technological expertise that is required 
for the e-consultation is not a big innovation. On the technology front, the innovation lies 
somewhere in the middle of incremental-radical innovation scale weighing higher towards the 
incremental side. The innovation requires acquiring a group of people who are willing to use the 
technology and pay for using it. There are people using technology in Norway to make health 
related inquiries and there are very few GP offices in Norway that provide similar service. So, 
there is a large group of potential customers who have not used the technology for such purpose 
nonetheless has little information about such possibility. There is a need to formulate a business 
model to target that market that does not have significant prior knowledge or concern towards a 
technology like this. So, the innovation in market is slightly disruptive. 
 
Similarly the e-consultation and epidemiological disease query practice hasn’t been applied in 
the GP offices in Norway.  The innovation brings about discontinuity in technology and market 
infrastructure at micro level i.e. in the firm and customer level. Most of the customers and firms 
have not used it yet and thus it will be quite new experience for both. However, the innovation 
also is expected to bring in some discontinuity in market infrastructures in industry level. Its 
utility is going to be a new endeavor for Norway in health industry since it has very few users 
until now. According to Garcia & Calantone (2002)’s classification, the innovation falls under 
really new innovation type due to the discontinuity it brings in the marketing infrastructures at 
micro and macro level. Considering all the information, the innovation involved in Erdusyk can 





















When a new disruptive target enters the market, it follows a certain pattern of adoption by the 
customers. The old technology adoption life cycle model consists of a smooth bell curve having 
customers of high-tech products, progressing from Innovators, Early Adopters, Early Majority, 
Late Majority, and Laggards. Moore (2014) has revised the old curve with a new model that has 
cracks between the customer groups. The largest crack is between the early adopters and early 
Majority which he also calls “the chasm”. (See appendix for the technology Life Cycle Model). 
According to him, many companies fail to cross the chasm while trying to sell a disruptive 
product to the mainstream customers. Erdusyk is a really new product and has a bit of 
disruptiveness and thus will struggle to make the leap over the chasm. The early adopters are 
visionaries and might accept the product. But there are really few early adopters and thus the 
chasm needs to be crossed to reach the mainstream market.  
 
According to Moore (2014), to target that group, one must be patient and be familiar with the 
issues that dominate their particular business. They should know about the availability of the 
Figure 4: Positioning of the innovation 
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product and the utilities and the product should be present at industry-specific conferences and 
trade shows such customers attend. Thus, Erdusyk needs to be mentioned in articles that run in 
magazines that such people read. There is a need to have partnerships and alliances with the ones 
who serve them already (GPs in this case).  To cross the chasm, Moore (2014) suggests focusing 
on a single smaller market, dominate over it and then attack the adjacent segments. Following 
the same premise, the initial target of Erdusyk is to focus on the handicapped and chronic 
patients first and then move on to offer the service to adjacent groups.  
 
2.10 Conclusion 
Erdusyk has been developed from years of research. The disease query engine and the 
epidemiological model have already been created. The two make use of the clinical informatics 
software ‘SNOW’ and the statistical tool ‘Emnet’ for the data extraction and computation. The 
epidemiology is created from the data from disease queries made by patients, health records at 
GP offices and the disease agent information from the microbiology labs. The interface for e-
consultation is yet undecided and there is a need to create a link between the diseases and the 
information about the diseases for the disease query once the commercialization is started.  
 
The sub-research question for the innovation study is, “What is the innovation level of Erdusyk 
and what value propositions does it provide to the potential users?”, and the chapter answers 
that question.  
 
The technology has values for customers and society and has a business value as well. The 
technology will eliminate the need for people to physically visit the doctor when the physical 
consultation is not warranted by substituting physical consultation with an electronic one. That 
will spare people with the discomfort of travelling when sick, wastage of time, and other 
problems associated with visiting doctors physically. The epidemiology model will provide the 
information about other people with similar problem which is of interest to many people. The 
epidemiological information can be used as a disease diagnosis support system for doctors, 




The technology can be positioned as an incremental-disruptive innovation based on Thomond, 
Herzberg, & Lettice (2003) and Dosi (1982)’s classification. Similarly, it can be positioned as 
Really New innovation under Garcia & Calantone (2002)’s classification based on the 
technological and market discontinuity brought by the innovation at micro and macro level. The 
product will strive to increase the proximity with the early majority group through collaboration 
with GPs and awareness programs through internet and publications. Also, the initial target will 
be the handicapped and chronic patient group. After that group is captured, offer will be made to 
other groups in closer proximity to the group. The target groups and the promotional endeavors 























3. Market Study 
 
3.1 Introduction 
The financial success of a company often depends upon the ability of a business to assess market 
information and use it in order to create leverage or an opportunity in the market (Kotler & Keller, 2009). 
Thus, to create that leverage and the opportunity, this market study will strive to obtain and assess the 
market information. This market study will answer following sub-research question: “Is there a real 
market potential for Erdusyk and which market strategy will lead to successful 
commercialization?” This market study will deal with performing an analysis of the market the 
company will operate in find out the market potential for Erdusyk. That, in turn, will provide an idea on 
how to enter the market in best possible way leading to development of a market strategy. This paper will 
first briefly describe the innovation, and then go for an analysis of the market the innovation will operate 
in. The analysis will determine the market size, growth potential and an understanding of customers, 
competitive scenario, market trends and the environmental impact. After the analysis is done, market 
strategies are formulated based on all the position of the product in the market. 
 
3.1.1 Description of the Innovation - Erdusyk  
 Erdusyk is primarily a disease query engine (DQE) equipped with a facility for e-consultation. 
The disease query engine (DQE) provides people with a search engine where people enter their 
symptoms and get suggestions on possible diseases they might have caught. The general concept 
behind this service is to provide people who get ill with relevant and quality information in order 
to assist in decision making regarding the treatment of illness and the doctor’s visit. It makes use 
of the epidemiological database for retrieval of information of diseases based on symptoms 
elicited by patients and provides facility for e-consultation for the people who need it. The 
epidemiology contains information from patient’s EHR (electronic health records) at General 
Practitioner’s offices, people’s searches at DQE and Lab Information System at Microbiology 
labs. The e-consultation can be in the form of text, audio or video interaction between the doctor 
and the patient. Currently it is a website and will also be designed as a phone application. ‘Er du 





3.1.2 Healthcare System in Norway 
The Norwegian healthcare system is well portrayed as a decentralized national health service 
(NHS). The fundamental aim of NHS is to provide all the residents with equal access to health 
services, irrespective of their location, gender, age, or financial status, and also to prioritize those 
who have the greatest need (Mørland, Ringard, & Røttingen, 2010). 
  
All the people in Norway are assigned to general physicians. Everybody is assigned to general 
practitioners who become their personal doctor. They are commonly referred to as GPs or 
personal doctors. When people are unwell they usually book for an appointment with their 
personal doctor first. So, the patient’s first contact with the health care system is usually through 
a GP (Bellika, Hasvold, & Hartvigsen, 2007b). General practitioners and nursing care are 
referred to a primary care services for patients. The 430 municipalities in Norway take 
responsibility for providing all the residents with these primary cares. 
  
 
Figure 5: Structure of Health care system in Norway 
 
The GP performs all the diagnosis and takes measures to cure it. However if the GP determines 
that a person needs further tests or deeper attention then the person is sent to a specialized doctor, 
a laboratory or a regional hospital based on the case at hand. After the reforms in 2002, it has 
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also been a responsibility of the state to provide the specialist care. This responsibility has been 
delegated to four regional health authorities (RHAs). They control all the hospitals and health 
enterprises in their corresponding regions (Mørland, Ringard, & Røttingen, 2010). According to 
Mørland, Ringard, & Rottingen (2010), there are 23 health enterprises and hospitals under the 
control of the four regional health enterprises. 
 
3.2 Market Study 
3.2.1. Customer Analysis 
Customer analysis identifies target customers, ascertains the needs of these customers, and then 
specifies how the product satisfies these needs. Customer analysis is a critical part of the market 
study that pinpoints exactly who the customers are, what they need, what drives their decision-
making and how the product meets their needs. According to Kotler & keller (2009), the aim of 
marketing is to meet and satisfy target customer’s needs and wants better than competitors. 
Through customer analysis, we look for the customer trends that suggest newer marketing 
opportunities. Customer analysis deals with understanding customers i.e., gaining a 360-degree 
view of both their daily lives and the changes that occur during their lifetimes so that right 
products are marketed to the right customers in the right way (Kotler & Keller, 2009). 
 
The medical system in Norway is a gatekeeper system. It is so in the sense that the admission to 
the system is gained normally through the personal doctor or GP who acts as a gatekeeper. A 
patient enters into the system through his/her GP. About 800-1200 people are assigned to a GP 
whose responsibility is to take care of the health of those people. The responsibility of so many 
people’s health to limited GPs can sometimes make it harder for many people to get health 
service in time. In the study of seven countries of Europe, Andreassen et al, (2007) found that 
46% of people use information on internet to decide whether or not to see a doctor. The study 
suggests that the information that people read on the internet might influence the number of 
patients visiting the doctor thus making it harder and easier for other people to receive timely 
health service.   
 
Many people feel it uncomfortable to physically travel to doctor’s office when they are sick. The 
questionnaire study conducted for this study shows that almost 53% of the respondents felt it 
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uncomfortable and 9% very uncomfortable to travel to the doctor’s office when they are sick 
(Refer to appendix. 2). Similarly, substantial population (about 40%) believes that they are 
dissatisfied with the late appointment date they receive for consultation. Similarly, 34.8% people 
have concerns about the time consumed during the treatment process. People are concerned 
about having to spend a lot of their time from booking the appointment, to travelling up to the 
GP office and waiting for their turn. So a need for a service that could eliminate the difficulty of 
travelling and wastage of time waiting in the clinic’s lobby exists. Similarly, substantial 
population of Norway seeks health information available in the internet while it is sick. 
However, many people have concerns over the authenticity of the information and credibility of 
the service provider. It is also common for people to try to know if there are other people at the 
moment who have got similar problem as them. It is also backed up by the response received 
from the study that shows about 63% of people wanting to know if other people have caught 
similar diseases.  
 
Erdusyk will provide a DQE as well as an e-consultation facility to the users. So information was 
collected from patients chiefly relating to their search of health information and their perception 
towards e-consultation. 145 people were asked whether or not they used internet to read medical 
information when they were sick. 75.9% of the respondents replied affirmatively further 
justifying the previous findings. So it is safe to assume that a lot of people would be willing to 
get access to the information that serve their requirements related to health. It was also seen that 
for almost 76% of the population, there was no specific source of health information search. A 
few of them used Google to search for diseases and few others had two or three websites that 
they chose to obtain the information from. Almost 62% said they were somewhat satisfied with 
the services and information they were receiving in the internet followed by 18% who were not 
so satisfied. It was also reported that almost 70% of respondents were skeptic towards the 
information provider. They had some qualms about the credibility of the information provider. 
45.6% people have doubts about the validity of the information and 36.7% of people believe that 
a large share of information displayed on the screen is irrelevant. 
  
Based on the above information, it is safe to assume that people value a service that provides 
precise health information based on their disease condition, that provides information on whether 
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other people have similar condition at the moment and that provides facility for e-consultation. 
Erdusyk combines all those services in a single bundle and offers the complete service to the 
people. The service is unprecedented in the market. Considering the amount of discontinuity the 
product brings in the market and the technology, the innovation involved in the product is 
classified as really new or incremental-disruptive.   
 
When a high-tech product disruptive to the market is introduced, the adoption of the product is 
done by Innovators, Early Adopters, Early Majority, Late Majority, and finally Laggards in that 
order. Moore (2014) suggests that there is a huge gap between early adopters and early majority. 
Early adopters are visionary and very few in number. Early majority are more skeptic and large 
in number. Early majority group is where the real dollars are and thus there is a need to cross the 
gap. The gap is quite huge and a lot of companies fail to cross it. Moore (2014) refers to the gap 
as “the chasm”. To cross the chasm, Moore (2014) suggests targeting a single smaller market 
segment first, dominate over it and then attack the adjacent segments. During the data collection 
process, some degree of skepticism was observed in a certain number of people about Erdusyk. 
Based upon the questionnaire survey, about half the respondents are not ready to substitute a 
regular consultation with an e-consultation when they are sick. Some people were found to be 
much critical of the use of such technology in health care system (refer to section 3.2.4.3).  In an 
attempt to cross the “chasm”, there is a need to focus on the people in the other side. The 
research points towards a need to initially focus on smaller groups who might be easy to target 
and have greater degree of utility for the product. The initial focus would be to satisfy some of 
their pains. This gives a breakthrough for the product in the market and develops avenues for 
acceptance of the product by overall market who would want to try e-consultation (77% of the 
respondents were interested in e-consultation). That way in few years time, Erdusyk could 
gradually incorporate the ‘Early Majority’ group.  
 
Some of the patient groups who might have better utility based on the suggestions from my 
interviews are listed hereby; 
 
- People needing sick letter from the doctor: When people are sick and they need a sick 
letter for the sake of alibi for not coming to work or school, they need to go to emergency 
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doctors and wait for hours. When people are actually sick, it is inconvenient to go to the 
doctors and wait for hours to actually get sick letter. In such cases, Erdusyk could play an 
important role is connecting doctor and patient virtually from home or work.  
- Handicapped people: These are the people who have trouble with physical movement. 
The trouble is even bigger when they are sick. Erdusyk can eliminate that difficulty by 
connecting them to the doctors as well.  
- Chronic patients: These are the people who need to visit doctors frequently and make 
frequent reports and consultations. Frequent visits to doctor is difficult physically and 
even more so when people are sick. Erdusyk can help them by helping exchange 
information and also render e-consultation.  
- People with social anxiety: This is a group of people who have an excessive and 
unreasonable fear of social situations; something that results from a fear of being closely 
watched, judged, and criticized by others. A person with this problem is afraid that he or 
she will make mistakes, look bad, and be embarrassed or humiliated in front of others 
("Social Anxiety Disorder", 2016). These people do not want to visit to clinics and would 
be willing to connect to doctors from internet.  
 
There could be many more niches than listed above. Use of Erdusyk for some private doctors, 
psychologists, research institutes, microbiology labs, etc. were also some suggestions that I 
received during my study. Initially, the general public was targeted before the market study was 
done. However, after the data collection and interviews, the bottlenecks and dead-end in the 
commercialization process begin to appear. The idea seemed to fall apart when it was known that 
the remuneration system of the GPs would be affected by the use of e-consultation. After 
expending a considerable time in further research, it was discovered that there was a way to work 
around the remuneration issue. Selecting a target market needed a good amount of further 
research on the target market’s pains, behaviors, requirements, regulations and the healthcare 
system for them. Due to a lot of time spent on the remuneration issue, further study on these 
target segments was not feasible for the project due to time limitations. So, based upon some of 
the accessible secondary data, chronic and handicapped people were selected as target market for 
the initial breakthrough. The significant population and potential high value of the technology for 
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them was the reason for their selection as the target market. The ultimate market however is the 
entire population having the pain. 
 
There is substantial population with chronic illness all around the world and in Norway. They 
have a need to visit the doctor frequently and also have needs for frequent tests. Often they also 
need to carry out some medications or smaller tests at home (for example taking insulin injection 
at home by diabetic patients) and provide the information to doctors frequently. In doing so, they 
have to travel to the doctor’s clinic for many minor concerns. Doing so is, in itself, an 
inconvenience they are believed to be willing to get rid of. Communication of minor issues that 
might occur as often as every day is a huge problem at the moment. For such people, the 
availability of e-consultation could be of a great value. Similarly, it is quite difficult for 
handicapped people to move around physically. Having to go to doctor’s office when they are 
sick is even difficult task. The population of handicapped and chronic patients is not too large 
and not too less and they have quite good utility for Erdusyk service. Hence, these two groups of 
people will be targeted as the initial target group. They will be the pilot group that will give 
Erdusyk a good insight about the service. This target group will provide the breakthrough to the 
service and will open up the avenues to offer service to general public in few more years.  
 
Across 59 countries in various parts of the world, the average prevalence rate of handicapped 
people in the adult population aged 18 years and over derived from the World Health Survey was 
15.6% in 2004 ranging from 11.8% in higher income countries to 18.0% in lower income 
countries (World Health Organization, 2011). The figure refers to adults who experienced 
significant functioning difficulties in their everyday lives. Norway being the high income 
country, the realistic percentage of disabled could be 11.8% of population. Similarly, 
approximately 4 per cent of the Norwegian population is estimated to have been diagnosed with 
diabetes (Dzidzonu et al., 2015). Similarly for COPD, most estimates from large-scale studies 
are between 5% and 10% ("Epidemiology - ERS", 2016). There are many forms of chronic 
diseases and it is not feasible to access the data at the moment. There is no available data on the 
population of handicapped and chronic people. Based on the above information, it is believed to 
be safe to assume the population of handicapped and chronic patients to be about 15%-20% of 
total population of Norway. For the convenience, it is taken that the total population of 
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handicapped who have significant difficulty in moving and chronic patients having to visit 
doctor 10 times or more in a year to be about 18%. That is the target market for the beginning.  
 
3.2.2. Competitor Analysis 
Competitor analysis is an assessment of the strengths and weaknesses of current and potential 
competitors for a certain product or service. It is important for every firm to know its 
competitors. It is imperative for a firm aiming to provide certain value to customers to know 
what other firms are providing for that particular need or other similar needs of customer. That 
way, the firm can formulate a strategy to create an appeal for the customers that is much different 
from what others are providing. According to Kotler & Keller (2009), building a strong brand in 
the market requires a keen understanding of competitors and only then marketers can best 
manage their own brands depending on the market position. The customer analysis involves 
identifying primary competitors and then ascertaining their strategies, objectives, strengths and 
weaknesses (Kotler & Keller, 2009).  
Based on the market potential review, it has been found out that significant proportion of people 
are interested to consume a service that has the capability of performing a disease query, 
providing health information and e-consultation. The next step now is to find out the main 
players in the market that are providing similar values to the customers. The two main services 
viz. Disease Query engine and e-consultation will be dealt with in the sections below. 
  
3.2.2.1 Disease Query Engine 
There are a lot of websites and phone applications that people are using to obtain medical 
information. There’s a huge amount of information available for people in the internet. However, 
only a handful of disease query engines exist at the moment. Some of the most popular disease 
query engines are presented hereby; 
 
Webmd.com: It is a US based health information provider. It has information about almost 
every disease existing at the moment. Present both as a website and as a mobile application, it 
has symptom checking facility. It is quite interactive, graphical and easy to use. It also has 
facilities such as pill identifier, family and pregnancy health news, and forum for people with 
certain disease to meet and share, and also opportunity for patients to book an appointment with 
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the doctor. It does not perform the epidemiological search and does not present the 
epidemiological information however.  
 
Drugs.com: It is a New Zealand based, basically, a Drug information provider hosted from the 
US. It provides people with a symptom checker, pill identifier, drug interaction checker and 
some other. Chiefly it provides information about drugs and that is its stronghold. It does not 
provide the epidemiological information that Erdusyk does. 
  
Isabelhealthcare.com: It has been dubbed as a diagnosis decision support solution for 
physicians. It is best known for Isabel, a web-based Diagnosis Checklist System, designed to 
assist clinicians that may have diagnostic doubt or want reassurance on a particular diagnosis. 
Doctors usually have the diagnostic procedure and a symptom checker does not have a huge 
value for doctors. It differs from the disease query engine function of Erdusyk which is focused 
on patients. Along with the symptoms, it also needs patients to enter their geographical areas that 
modifies search according to the area the patient lives in or has recently travelled from. That way 
the search is more narrowed. However, the epidemiological information is not provided by it 
either.  
  
Mayoclinic.org: Mayo is a foundation for medical education and research. It is a huge non-profit 
organization that has many medical campuses in the US. They have a huge quantity of 
information about large span of health issues. It contains information about diseases, healthy 
lifestyles, drugs and supplements and a symptom checker. It also has options for people with 
certain disease conditions to meet together and share their experiences. It also has a feature for 
booking appointments online with doctors near the locality of patients. Overall it is a huge 
service organization that strives to provide as much medical information to general people as 
possible. It has comprehensive information about various health issues. It does not however, 
have epidemiological information either.  
  
Healthline.com: It contains information about the diseases, drugs, healthy living, drug identifier 
and many more. It has option for symptom checking and also connects cancer patients with 
cancer specialists for a fee. The symptom checker however is not too interactive. It has a list of 
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symptoms to choose from and provides a long list of possible diseases that follow the symptom. 
It is hard for patients to know the closeness of the symptom and the diseases. It is not too 
advanced and interactive in disease query and it does not provide epidemiological information. 
 
Everydayhealth.com: Just like other health information websites, it contains information about 
several diseases and health conditions, drugs, supplements, healthy living and food and nutrition. 
It also provides a symptom checker and also searches for medical personnel around the locality 
of patients for appointment. It provides a pre-recorded video of a doctor who speaks to the users 
performing symptom check. It does not provide the epidemiological information either.  
  
3.2.2.2 E-consultation 
There are several online sites those provide e-consultation in Norway and internationally. Not all 
health information sites have facility for e-consultation. Some of the most popular websites 
offering e-consultation are presented hereby. 
  
Telephone/text services in GP offices: Some of the GP offices in Norway provide patients with 
options to connect to doctors through telephone or through emails. Patients express their 
problems to doctors through telephones and emails. Patients who need extra tests are summoned 
to the GP offices, and those who don’t, receive the prescription right back. 
  
Helsenorge.no: It provides information about the GP, GP offices and has all the features to 
choose and change one’s personal doctor. It is a government hosted website dedicated to serve 
people by helping people select desired personal doctor for them. It is known to be trying to set 
up an interface to store every individual’s health records. It is also trying to gather infrastructures 
for e-consultation. Competitiveness between Erdusyk and Helsenorge.no is discussed further 
below  
 
 Nettlegevakt.no: It provides an internet based doctor service as it proclaims. It is dedicated to 
treatment of urine infection in women of age group 16-55. For normal doctor’s fee, they look at 
patient’s symptoms sent to them via internet and decide on the medication. They create an 
eResept for pharmacies in the same way as ordinary Doctors. They do not provide any service 
42 
 
for other cases and the doctors are private ones. They only provide e-consultation in the form of 
text. People do not receive health care from their own GP. 
  
Onlinelege.no: This is a website that is quite dedicated to providing e-consultation. E-
consultation is their primary offer to the customers. Paying a fee, people text their problems and 
conditions to doctors and the doctors respond back with suggestions. The fee depends upon the 
promptness of the response and privacy of the response. Here, too the people do not get 
consultation from their own GP. They provide only text form of e-consultation.  
  
Lommelegen.no: In addition to the health information, it provides an option for e-consultation. 
People can send in their questions to doctors who will respond back for a fee. Both the GPs and 
experts are available for the consultation. It also however, does not connect the patients to their 
own GP and they too provide only text form of consultation.  
 
 Healthline.com: Has option for getting a second opinion from a top, independent oncologist in 
an attempt to offer peace of mind, and potentially even save patient’s life. It provides, to a paid 
member of the group, an option to get second opinion about the patient’s case from cancer 
specialists for a fee. It is dedicated for only cancer patients.  
  
Healthanswer.com: It is a website that deals with getting patient’s questions up to the doctor for 
a fee. It provides an option for e-consultation with a doctor where doctors provide answers to 
different queries of people from all around the world. It is an international internet site and it is 
probably tougher for doctor to understand the epidemiological information if a patient from 
different location calls. There’s also no own GP involvement there.  
 
3.2.2.3 Competitive Scenario 
Some of the players mentioned above will be evaluated on whether or not they provide symptom 
checker (a Disease Query Engine tool), epidemiological search, facility of e-consultation, 
updated epidemiology and health information services. These are some of the services that 
customers are known to value and that make the service better. Some of the major health care 
service providers and their offerings are compared below. 
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Helsenorge.no 
      
Nettlegevakt.no 
      
NHI.no 
      
Onlinelege.no 
      
Legehandboka.no 
      
Webmd.com 
      
Drugs.com 
      
Isabelhealthcare.com 
      
Mayoclinic.org 
      
Healthline.com 
      
Everydayhealth.com 
      
Uptodate.com 
      
NHS.uk 
      
Healthanswer.com 




 As it can be seen that there are a number of health information providers in the market and each 
of them has their own forte, it is wise to see which of the competitive players have been offering 
the values that we aim to offer. There is no other website or an application that provides the 
combined service of disease query, epidemiological information and e-consultation. As we 
know, people have need for credible source of precise disease information, people want to know 
if other people have similar cases and people want to try e-consultation. Erdusyk is the only 
product that provides all the service. It has been observed that no other competitors are providing 
the combined service of health information, disease query engine and e-consultation.  
 
There are some world leaders in medical information providers such as mayoclinic, webmd and 
drugs.com but they do not offer epidemiological information for the disease query. None of the 
disease query engine provide epidemiological search. Thus, they do not provide information if 
other people around have similar cases as inquired or not. People would like to know if there are 
other people searching with similar cases, and what measures they are taking. That information is 
not available anywhere at the moment. Even though few of them have epidemiological approach 
in the search, the epidemiological information that they have isn’t up-to-date (e.g 
isabelhealthcare.com). The epidemiological information that Erdusyk has is unprecedented and it 
is updated in daily basis that makes it quite useful and makes the diagnosis more meaningful. 
 
Also, there is no service that provides e-consultation in the form of text, audio and video with the 
personal GP. Some of them provide it only in the form of text. The consultation that they provide 
is not with the personal GP that makes it even undesirable. A private GP needs to understand the 
patient’s history first before the treatment can begin and the process repeats with every 
consultation with new doctor that makes the consultation even more complicated.  
 
Helsenorge.no is a Norwegian online health service provider that provides information on 
booking appointments, receiving prescriptions, conducting an e-consultation and having contact 
with the GP office if the GP provides such facilities and has made the information available at 
helsenorge.no. It is trying to build something that is closest than the other competitors to what 
Erdusyk is trying to do. However, Erdusyk has a better infrastructure and efficient ways of 
performing. Under Helsenorge.no, the government is trying to build a central database called 
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‘kjernejournal’ that stores every person’s health records in a single server. GP offices own the 
information of the patients. That approach of storing information in a single reservoir and away 
from the information owners might be vulnerable to misuse and might jeopardize the security of 
people’s private information. Also, it needs doctors to store every patient’s information in the 
server per every consultation. Similarly, storing in a single server needs some encryption of data 
and it is not possible to reuse the data for other purposes in the future. It is for these reasons, 
many GPs might not agree on providing their private information. Under Erdusyk however, the 
data remains at the owner’s location. There is also no need for the doctors to store the data in any 
external server. Doctors have all the rights over their data and thus the data are more secured.   
 
For the target group, handicapped and chronic patient, it is necessary to have information 
exchange with their personal doctor without the hassle of travelling to their clinics frequently. E-
consultation is the best alternative for them. They could spare the trouble of travelling up to the 
clinic until the actual need to travel occurs. There is nobody providing that service in Norway for 
the handicapped and chronic patients.  
 
3.2.3. Market Analysis 
Market analysis describes the market for the service as it exists today. Through the market 
analysis a company can minimize its uncertainties and can lay down the foundations for 
decisions on market strategy (Burns, 2007; Kotler, Armstrong, Wong, & Saunders, 2008). This 
section focuses on the macro-level market dynamics such as market size, market growth, and 
future trends. It describes the electronic health service in Norway at the moment and how it is 
evolving. Also, this section provides perspective about how favorable the overall market 
conditions are for Erdusyk at the moment. 
 
Internet has been an important part of life nowadays. Internet has slipped itself into a lot of 
aspects of daily life. Communication, entertainment, education, health are just some of the 
aspects of life internet has influenced by a substantial degree. Internet has in the same way 
created many novel and promising opportunities that wouldn’t have been realized otherwise. 
This shift towards the use of internet in various aspects of life is soon to be diffused in the health 
service as well. Many entrepreneurs are of the idea that digitization of healthcare service is going 
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to happen for sure in next 5-10 years. The question is who is going to do it and how. Erdusyk is 











A lot of 
people 
use 
internet to collect information about a lot of things and health is not any different. It was also 
found out that about 80% of the population in Norway uses internet. That is a substantial portion 
of the overall population. A study by Andreassen et al. (2007) has revealed that almost 74% of 
internet users in Norway seek health information through the internet. As shown by the figure 
above, there is an increasing trend of using internet for health related services in Norwegian 
population. That represents a significant opportunity for internet based health related products 
that could provide value to people.    
 
The information is also verified by my research where 77% of the respondents have verified that 
they seek medical information from the internet when they are sick. Almost 3.85 million people 
in Norway look for medical information when they are sick. There are 63% of respondents 
wanting to know if other people have caught similar diseases, a need fulfilled by epidemiological 
data. If that data is to be followed with the assumption that the responses are unbiased, that 
makes almost 3.15 million people in Norway. A fascinating 77% of respondents are interested in 
a service that allows them to have an electronic-consultation with their GP. That is 3.85 million 
people. That includes 3.1 million people (62%) who are willing to pay for that service. 
Figure 6:  Increase in use of the internet for health purposes in the Norwegian 
population by age groups (Wangberg et. al. 2009). 
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Also, a meager calculation of the population of the handicapped and chronic patients done in the 
customer’s section above is of about 18%. It is assumed that they have greater pains in physical 
consultation and thus the greater needs for e-consultation. That accounts for 0.9 million people in 
Norway. SEDA report concludes that just a little under 50% of consultations in Norway have 
diagnosis of a chronic disease (Brøyn, Nina, Elin, & Inge, 2007). That is a significant number of 
consultations. However, not all the consultations of chronic patients can be substituted by e-
consultation at the moment. When asked about how many consultations can be substituted by e-
consultation, a doctor replied, “It would vary greatly according to the GPs experience and taste 
how many could be substituted, perhaps 10 to 20%. Only a proper study involving many doctors 
will give a proper answer.” It is believed that about 20% of all consultations involve those 
handicapped and chronic patients, whose consultations can be substituted by an e-consultation.   
 
This is a quite novel concept and there is not too much data available on the perception of 
market. The internet and the communication technology have been more accessible to people 
now more than ever before. More and more people are using mobile phones and computer for 
many activities that was previously done physically or in some other way. According to 
Wangberg et al. (2009), use of the internet for health purposes is growing in the Norwegian 
population, and so it the importance of the medium as a source of health information. The study 
by Wangberg et al. (2009) also shows a trend towards a more positive attitude towards future 
uses of the internet channel for health-related communication and also trading for health-related 
products. There have been many ideas in the past, some even considered for master’s thesis that 
made use of technology and the internet but were cut short by some technical limitations. Now, 
such technological hurdles have been crossed and the ideas seem more realistic now. Since, 
technology and internet are increasingly at customer’s disposal, the idea of digital health care is 
possible now. With the trend of online transaction and online services increasing, electronic 
consultation is just another click away. 
 
3.2.4. Environmental Analysis 
Environmental analysis is a critical tool for strategic marketing. It is a process to identify all the 
external and internal factors that can affect the performance of an organization. The market 
changes every day and new things develop over time so that the whole scenario is frequently 
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changing. Businesses are greatly influenced by the environment they operate in and those 
environmental factors are quite unpredictable. So, businesses must constantly analyze the 
environment and the market. According to Kotler & Keller (2009), marketers find many 
opportunities by evaluating trends and megatrends (changes in the environment that have long-
lasting influence).  
 
The primary health care process chiefly involves two parties viz., the patient and the doctors. The 
utility of Erdusyk can be seen for both the parties. Some of the pains of the patients are eased by 
Erdusyk but doctors have some benefits from it too. Access to epidemiology is something that 
helps doctors in diagnostic decision making. Similarly, incidences of transmission of diseases 
from patients to doctors are substantially low. For that reason, one would assume that doctors 
would be happy to utilize Erdusyk in treatment process. However, there are some factors that 
discourage doctors in using Erdusyk. We will have a look at those through an analysis of 
political, economic, social and technological environment.  
 
3.2.4.1 Political Environment 
The regulatory and the remuneration system of GPs in Norway are not conducive enough for the 
doctors to adopt e-consultation. Doctors receive a certain portion of income from municipality, 
some portion from the state and rest from the patients per consultation depending upon the nature 
of consultation. They earn much lesser amount from the state for the e-consultation rather than 
the normal consultation. Also, there are different regulations for different forms of e-consultation 
for doctors. One of the doctors who was interviewed had this to say, 
 
It’s very odd! If you send me an e-mail and I reply you back then you’d have to pay! If I talk to 
you on phone then you wouldn’t have to pay! But if you send me an e-mail and you want me to 
send you a letter back then you wouldn’t have to pay!  
 
Concerning the video consultation however, there is a different requirement. The doctor said, 
“If you and I were in my office and we were talking to a nurse on a video, then it’s okay! Or if 
you were home with the nurse and I was in the office, then that’s okay! But if it’s only you and 
me or you, me and another doctor! Then it’s different! It’s crazy!!..........If I as a GP want to get 
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paid for my video consultation, I need to make sure that there’s somebody else beside you...could 
be a nurse, a physiotherapist!”  
 
The consultation performed only between the doctor and patient through video is not included 
officially in e-consultation and thus in not paid by government. So for the payment of such 
consultation there needs to be agreement between patient and the doctor on who is going to pay. 
“If we decide, you and I, that we do it on video and you pay me, that’s okay”, said the doctor.  
 
The political system in Norway is not favorable for the service yet. Even though the government 
is trying its best to provide medical information through internet and it’s actually doing good in 
that part, it hasn’t been aware about the pains of patient who need to travel to doctor’s office for 
cases that they don’t have to. The regulation about the e-consultation puts this service into 
jeopardy.  
 
The doctor further says, “The reason why is it so is because the government thought that the 
video consultation would be used when we have meetings with other professionals…...what we 
are working on now is to tell government that this is crazy.”   
For that reason, doctors are not quite excited about the use of e-consultation. Without that, the 
idea will suffer. There is a way to work around the remuneration issue. If a video consultation is 
summarized in the form of text and an e-mail is used, it will count as a consultation in the form 
of text and the remuneration issue will not be a problem. For the idea to stand, it is assumed that 
the way to work around the remuneration issue is possible and accepted.  
 
3.2.4.2 Economic Environment 
Norway is one of the richest countries in the world. Government has a welfare fund that takes 
care of all the residents of the country. Norway has a high per capita income and people have 
more resource at their disposal for health service than elsewhere. That is even favored by the 
health service being subsidized by state. People have greater affordability for the newer health 




Medical facility in Norway is to a substantial part state funded. The government of Norway pays 
almost half the doctor’s fee for patient’s each consultation with the personal doctor. Patients 
have to pay about 140 NOK per meeting with doctor. The fee for specialist’s service is a bit 
more at about 310 NOK per meeting. The medical service is free only for children below 16 
years of age and pregnant women while the rest have to pay. However, after the patients have 
paid about 2040 NOK in a year they receive an exemption card for the year and they do not have 
to pay any more medical charges that year. Economically, the product has little concerns.  
 
3.2.4.3 Social Environment 
There was a bit of skepticism noticed in some of the respondents that I talked to during the data 
collection about e-consultation and the bundle of service that I propose. One person, in 
particular, was quite vocal about it and said, “Probably such sensitive health issues should not be 
touched and not made a business out of.” The person even declined to participate in the 
questionnaire survey. So, even though there are a significant number of people who have trouble 
with the current healthcare system in Norway, not everyone is ready to adopt electronic health 
care system as proposed by Erdusyk. Reports also show however that there are almost half the 
people who would want to substitute a real consultation with a virtual one. People in Norway are 
particular touchy about their privacy issues which Erdusyk has no problem taking care of. All in 
all people are more inclined towards accepting such service.   
 
3.2.4.4 Technological Environment 
The technological development at the moment makes Erdusyk more possible now than ever 
before. Due to the high per capita income in Norway, people have quite high and rapid adoption 
of new technologies. It is believed that the mobile phone penetration in the Norwegian market is 
almost close to 100%. Similar percentage of population owns a computer. Regarding 
technological development within the healthcare system, it is found out that 98% of the 
Norwegian GP uses a computer and 87% have a disposal to Internet connection (International 
telecommunication union, 2004). That data is quite old and the disposal to internet and the fact of 
owning a computer could be as close as 100% now. Technologically, this space-time is well 










• First DQE in Norway 
• Maintained privacy of patient’s 
information 
• technical expert group 
• years of research 
• Statistical processing capability 
• Daily updated epidemiology 
• Value for patients, doctors and Gp 
offices and even government 
 
 Weakness 
• Dependent on GP and GP office's 
consent/need for collaboration 
• Lack of investment capital  
• No patent possible for software 
• Hasn’t been tested yet 
• Group of researchers/lesser business 
motive 
 Opportunity 
• Nation-wide scope.  
• increasing number of people willing to 
try e-consultation 
• no norwegian  DQE exists yet. 
• greater availability of internet and 
required infrastructures 
• growing trend of digitization  
 Threats 
• New disease Query Engine in Norway 
• Many stakeholders 
• Very sensitive health issues  
• skepticism among  the population 
• Government intervention 
• Remuneration system of doctor making 
them unwilling to try e-consultation. 
SWOT 
SWOT 
From all the factors related to the product, it is now quite important to locate where Erdusyk is 
and what is the way forward. The first step in the process is to create a SWOT analysis. SWOT 
analysis is a tool that helps us to recognize business’ strength and weaknesses as well as the 
opportunities and risks posited by the environment upon the business. The strengths and 
weaknesses are identified by an internal appraisal of the organization and the opportunities and 
threats by an external appraisal. After identifying these factors, strategies are developed which 
will build on the strengths, eliminate the weaknesses, exploit the opportunities and counter the 






















 Figure 7: SWOT analysis 
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Development of exclusive infrastructure through research capable of generating epidemiological 
information that could be updated in a daily basis is one stronghold for the developer. The 
concept of Disease Query Engine in Norwegian is first in Norway.  The Snow research team has 
been conducting research in the sector for a long time and has strong technical group. The 
appliance box set up in the GP offices has a good statistical processing capability that generates 
epidemiology and other medical information based on disease incidences over relevant 
geographical area. 
 
For Erdusyk to perform, the appliance boxes need to be set up in GP offices and microbiology 
labs. So, consent from GP offices is required and collaboration with them is required for the 
product to work. For setting up the appliance boxes and starting the company up, initial 
investment is needed that is lacking at the moment. The software inside the computer boxes is 
what makes the DQE and e-consultation worthwhile. The software is developed with years of 
research and could be vulnerable to property right infringements. However, in Norway a 
software cannot be patented that might increase the intellectual property risks. The device hasn’t 
been tested yet and the effectiveness of Disease Query Engine to provide Diagnostic Decision 
Making for patients is not known for sure yet. The developer group is a team of technicians and 
researchers having lesser motivation and means for commercialization. 
The environment that the product will be operating in posits some opportunities for the product. 
First of all, the epidemiological information is useful for both doctors and patients. Since 
everybody is precarious to health problems in their lives, it has a huge scope. The language being 
Norwegian, the website could be used by all in Norway. There is an increasing willingness, 
particularly in young people, to try out e-consultation. Growing trend of digitization in different 
avenues of life opens up possibility for digitization in health service and hopefully easier 
acceptance of the digitized health service by the people. Also, the internet and all other 
infrastructures needed for the product to operate are better now than ever before. That makes it 
possible and much easier for the product to operate. 
 
However, the disease query engine for diagnostic decision assistance for patients is a rather new 
concept. For such a new idea, there’s always a lot of skepticism in public. Health issue is a very 
sensitive issue and any product that is involved with health issue is countered with a lot of 
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skepticism. The product is supposed to provide patients with information in order to make 
simpler disease related decisions. In extreme cases, this might lead to dangerous results. The 
subtleties of the influence have to be measured and necessary measures taken to avoid such 
situations. There are a lot of stakeholders in this product and that increases the unpredictability of 
the product. Withdrawal of support from any one party could fail the product. Government 
remuneration rules, as already discussed above discourages doctors to use e-consultation. That 
being the case, the current regulation discourages the idea even though there is a way to work 
around the case.  
 
Conclusion of SWOT 
The strong weakness lies in the fact that there is a need to collaborate with GPs and GP offices. 
If the GP offices are unwilling to set up the box, then the idea of generating epidemiological 
information will suffer and also so will the e-consultation. GPs and GP offices should be 
informed about the values they are going to receive from the installation of the box. Also, a lot of 
people are skeptic towards a new product, especially when it concerns the health of the people. 
There should be a strategy to introduce it into the market and see how effective it is. Starting 
with chronic and handicapped patients is a good way to break through the market as they have 
the stronger need for e-consultation. That way the possibility of acceptance of the technology by 
other patients and the doctors could be evaluated. There are some GP offices already providing 
consultation through telephone. So, e-consultation should not be a problem. The effectiveness of 
Disease Query Engine is however relatively unpredictable. Starting with few pilot tests would 
help us to assess that condition and opt for a future strategy to extend the patient group. The 
biggest threat however is the payment system of GPs. There would be no way around it. So, we 
would assume that the payment system is not significantly unfavorable for the doctors and they 
are quite indifferent towards it.  
 
3.3 Marketing Strategy 
According to Baker (2000), the strategy is needed to bring the focus to our actions. Similarly, the 
aim of a market strategy is to develop a long-term vision that will shape our immediate tactical 
decisions (Moore, 2002). This section will first present the long term vision of the company. 




The long term marketing objective is to develop a full-fledged epidemiology and possible e-
consultation from all the GPs and GP offices in Norway. Only then, all the patients can receive 
an effective disease query engine and possibility for e-consultation with their GP. The 
development of epidemiology and e-consultation is dependent upon one condition that the 
computer box is set up in the GP offices and hospitals. So a full-fledged epidemiology refers to 
setting up the computer boxes in all the GP offices, hospitals, and microbiology labs in Norway. 
  
Short term objectives are to set up the computer boxes in most possible GP offices in Troms and 
Finnmark County within a year. That way the DQE and e-consultation can be possible for all the 
people residing in that area. Also, within that time span, all the chronic patients and handicapped 
people in that area will be able to receive e-consultation from their doctors. Health issue is so 
complicated and it is difficult to create a demand for a technology like this. It is found that 
doctors are unwilling to break the conventions and patients are afraid of trying new technology. 
So the usefulness needs to be manifested slowly and subtly focusing on smaller group and then 
creating demand for others. That group of people has greater need for e-consultation and we are 
going to provide that in the beginning. 
 
Marketing Mix Decisions  
To achieve the marketing objectives, a company should have certain strategies regarding its 
marketing activities. The term “marketing mix”, often referred to as the “4Ps”, is a means of 
translating marketing planning into practice (Bennett, 1997). It is a mix of marketing procedures 
and policies used by marketer in an effort to realize a successful market vision. The marketing 
mix can be defined as the set of tactical marketing tools that the firm blends to produce the 
response it wants in the target market” (Kotler & Armstrong, 2013). Hereby the strategy for four 
marketing mix components is discussed to achieve the marketing long term goals; 
3.3.1 Product 
The product is known as Erdusyk which is a disease query engine that includes facility for e-
consultation. It provides customers with information about the diseases based on the symptoms 
of that particular person and the epidemiology of the place around. The disease query engine 
gives; (i) information on what disease the person might have caught (ii) data on how many other 
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people have caught the disease recently and (iii) information on what actions other people have 
taken for the cure. The action, here, refers to what percentage of the people consulted their GP 
and what percentage did not. The product works such that people get suggestions, based on their 
symptom, on what disease they might have caught. They also get information about those 
possible diseases. Then, they are offered an option for e-consultation for whosoever might want 
to receive a consultation through computer or mobile phone. Generally people with minor issues 
are believed to use the e-consultation service.  
 
The epidemiology and e-consultation service are provided under premium subscription scheme. 
Here the people pay the subscription fee and get the service for free. Or, for people who do not 
want a premium scheme, e-consultation is available as a stand-alone product. People pay for the 
doctor’s fee and the service charge. The disease query engine is available for all for free. Disease 
query gives information on what disease the person might have caught and epidemiology model 
on how many other people have caught the disease recently and where, and information on what 
actions other people have taken for the cure. The action, here, refers to what percentage of the 
people consulted their GP and what percentage did not. Then, they are offered an option for e-
consultation for whosoever might want to receive a consultation through computer or a phone.  
For the initial target group, the main product is e-consultation. These people have, at times, 
higher utility for e-consultation than any other group. The product is basically the same for the 
initial target group and the ultimate group. The emphasis is more on e-consultation for the initial 
target since they have higher difficulty in movement. However, they also need general medical 
information as everybody else which Erdusyk will provide. The benefits for the people from 
Erdusyk are reduced convenience, reduced wastage of time as well as the epidemiological 
information.   
  
Erdusyk is available as a website and also as an application for mobile phones and tablets. 
People can do the disease query without any identification. For, epidemiology and e-consultation 
however, they will need to set up an account in Erdusyk first. Disease query and the health 
information will be available for free. However, they will need to pay for the epidemiological 





The value of Erdusyk will be mostly for patients and thus it will be paid for by the patients. The 
promotional activity is basically targeted towards the patients. However, since the computer 
devices need to be setup in GP the offices, promotional activities need to be directed as well 
towards the GP offices and GPs. 
 
First, the managers at GP offices need to be contacted individually by the company manager. It is 
important to let them know about the benefits of setting up the appliance boxes in GP offices for 
them. The knowledge of epidemiology is much helpful for doctors for diagnostic decision 
making and that benefit should be hyped. Besides the access to epidemiological data, lower 
number of waiting patients in the queue and lower transmission of diseases through or among the 
waiting patients are some of the benefits the GPs and GP offices can have. These benefits need to 
be communicated comprehensively to them. Similarly, they should also be assured that the 
device for the Erdusyk will not in any way impinge the privacy and integrity of their database. 
Similarly, Erdusyk will present the importance of epidemiological data and its influence on 
diagnostic decision making in health conferences obtaining service of some telemedicine 
personnel from the Snow group. This is a way to make the doctors more aware about what 
Erdusyk is planning to do and make them more acceptable for the installation offers. 
 
For initial customer target, the e-consultation facility of Erdusyk will be introduced through GPs. 
Handicapped people and several chronic disease patients have unions and interest groups. People 
will be made aware about the availability of such service through promotional campaigns at 
union meetings. Also, a new study reveals that health marketing dollars might be better spent 
targeting the caregivers of the consumer group, rather than marketing to older and handicapped 
group themselves ("Healthcare Marketing and the Internet: To Reach Older Adults, Target 
Caregivers", 2016). As such, the caregivers will also be made aware of the product through 
advertisements through the internet and social media. Caregivers can influence the healthcare 
decisions made by handicapped and chronic patients and thus they should be considered for the 




After the initial target has been achieved, the internet, news media and social media will be used 
to promote Erdusyk to the general public. The stories of patients receiving the benefits will be 
shared through newspapers and television and radio. Similarly, advertisements will be posted in 
the most popular health websites such as NHI.no and elite health websites in Norway.  
 
3.3.3 Place 
The appliance boxes are bought from a wholesaler supplier and the program is installed in them 
by the technical staff of Erdusyk AS. The appliance boxes are shipped to the GP offices which 
agree to connect the devices in their system. It is so easy that anybody from the GP office can 
plug the box into the system and it will start functioning on its own without anybody even 
noticing any change in their system. The assistance, if needed, will be provided by our technical 
staff.  
 
As soon as the box is set up, it becomes able to extract electronic health records (EHR) 
anonymously for the statistical calculation as per the disease query. The epidemiology extracted 
by the device keeps on updating itself with the recording of new EHRs by doctors. There is a 
factor of trust from GPs that plays an important role. They should trust that the appliance box 
does not impinge the privacy and integrity of their data in any way. Contractual agreement 
between the GP offices and Erdusyk will be done regarding the extraction and use of HER which 
might help alleviate the problem to some extent.  
 
As soon as the computer box is plugged in, the disease query engine and the e-consultation 
facility will be available at https://www.erdusyk.no. It is a Norwegian website and people get 
access to the service through the website. However, it will also be developed as a mobile 
application for those who want to use it in their mobile phones. The website is available for 
access by everyone and the application is downloadable through the app store. 
 
3.3.4 Price 
There are few existing online services that provide e-consultation. People enquire doctors 
through texts and doctors reply their queries. They charge 200-260 NOK per enquiry, a 100 
NOK extra for swift reply within a day and 100 NOK extra for private reply. Some of them have 
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feature where doctor even write electronic receipt with which patients can buy medicines from 
pharmacies. The medical information is however free of cost and there are a number of websites 
providing that. NHI.no for instance has comprehensive information about almost all the diseases 
and healthy living and many other health aspects. However, nobody has the epidemiological 
information and that is quite valuable. 
  
With Erdusyk people will have an option to read general medical information and symptom 
search. However, for comprehensive search and epidemiological comparison, people need to 
have a premium membership account at Erdusy. People with the premium account are able to 
fetch epidemiological data and be able to connect to the doctor. People can buy a yearly 
premium account for 200 NOK. A monthly account will cost 50 NOK and a semi-annual 100 
NOK. It will allow them to acquire epidemiological information and an option for e-consultation 
through the account. Every e-consultation will cost equivalent to doctor’s fee. For people who do 
not want to have a premium account, they will have to pay 30 NOK in excess to the doctor’s fee 
for each consultation.  
 
3.4 Conclusion 
The study focused on identifying the product and the service and the market segments that had 
the biggest potential of the product leading to commercial success. Additionally, it gave insights 
on the competitive scenario, market conditions and the environmental factors affecting the 
commercialization. The process eventually led to providing important insights into making the 
best possible market strategy and business plan for launching Erdusyk in the commercial market. 
The sub-research question for the market study “Is there a real market potential for Erdusyk and 
which market strategy will lead to successful commercialization?” is finally answered.  
 
Based on the analysis it was found that the utility of the product would be for the patients, 
doctors and GP offices. The utility was much higher for patients and they are the ones who 
would be ready to pay. The questionnaire survey showed that 77% of respondents want to try out 
electronic consultation and about 63% are willing to pay for it. The competitive scenario is quite 
favorable too as there is no other service that provides the complete offer as done by Erdusyk. 
The competition is not too significant. Increasing number of people opts to use internet for health 
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related issues, and almost entirety of population in Norway has access to a mobile phone or a 
computer. Internet access is no different. The economic status of Norwegians is quite well with 
most of the people having affordability for health related services. The market, competitive, and 
environmental scenario were quite favorable. However, there was also a bit of skepticism seen in 
some of the respondents about the technology. That reflected the characteristics of people on the 
other side of the chasm as in Moore’s (2014) technology adoption cycle.  Following Moore’s 
(2014) premise, a smaller group is being targeted first as the technology is quite new and 
disruptive. For the initial breakthrough, chronic and handicapped patients from Tromsø would be 
targeted. The reasons for that target group were the greater need of e-consultation for that group 
and the technological convenience at the moment. 
 
The product will be accessible through a website of through a mobile phone application. The 
product will be available in the form of a subscription or as a single transaction. The medical 
information, epidemiological information and e-consultation charge will be exempted for 
subscriptions while they will be charged for single transactions. The price of the service was 
derived from competitive pricing method based on what other parties are charging for e-
consultation in the market. However, for greater market penetration, the price will be quite 
lowered. Subscription will be available for 200 NOK for a year, 100 for half a year and 50 for a 
month. The promotional activities will first include introduction of the service through doctors. 
The pilot group will be used to endorse the utility of the service to other customer groups. 
Finally, extensive promotion through advertisements in the internet, health websites, social 
















4. Business Plan  
 
4.1 Executive Summary 
 Erdusyk is a disease query engine with a facility of epidemiological disease search and e-
consultation. It was developed by a university based research group called ‘Snow’. It has been 
found out that many people have difficulty in travelling when ill and that many consultations 
with doctors can be electronic. It is also known that significant number of people use internet for 
health related searches and want to know if there are other people around having similar problem 
at the same time. Since, the product caters to a big problem that people are ready to pay to get rid 
of, it has a business utility.     
 
Being a disruptive product, the product will first be offered to chronic and handicapped patients. 
That group constitutes of 15-20% of the total population and will serve as the pilot target group 
for Erdusyk. After that, related customer groups will be targeted until eventually increasing the 
focus to include the entire population.  
 
E-consultation and epidemiological search needs doctors and information from doctor’s clinic 
respectively. Thus, doctors are an important member of the value chain activity. Besides the 
value of diagnostic support system and some other information, doctors will receive certain 
percentage of revenue from the consultations made electronically in excess to their normal 
consultation charge.   
 
The services will be offered at https://www.erdusyk.no where customers will get two options to 
use the product. First, customers can buy a monthly, semi-annual, or annual subscription 
allowing them to get epidemiological information for free and e-consultation for doctor’s 
ordinary consultation fee. Or, customers can opt to use e-consultation as a stand-alone product 
where they will pay certain amount in excess to doctor’s consultation fee as a service charge.   
 
The service needs an infrastructure to be built first. A minicomputer with special software 
installed by the inventor group will have to be installed in the doctor clinics. Starting from 
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Tromsø, the devices will be installed to Finnmark and then other counties starting from the one 
having the highest population. The business is valuated at 46 million NOK and needs an 
investment of 11 million from potential investors in return to 30% ownership of the company.  
 
4.2 The Pain 
As weak as illnesses make people, they have considerable degree of discomfort in visiting their 
personal doctor when they are sick. The way the health care system in Norway currently is, 
people need to visit the doctors physically for all diagnostic and treatment process. But there are 
many cases that do not necessarily warrant the physical consultation between the doctor and 
patients. Many follow-up consultations, cases of minor flues, visits for some confirmations, and 
need for sick leave are some of the cases that do not necessitate physical contact between doctors 
and patients every time. This business plan will serve to assess the commercialization 
potentiality of Erdusyk. For that purpose, a market research was done in order to find market 
behavior (Refer to chapter 3 for the market study). Based on a questionnaire research conducted 
on 145 people, it was found that 62% of respondents said they felt uncomfortable to travel to 
doctor’s office when they are sick, including almost 10% of people who felt very uncomfortable. 
Almost 77% of people are interested in a service that allows them to have consultation with their 
personal doctor online i.e., in text, audio or video forms through the phone or a computer. An 
emphatic 47% of people would actually prefer to consult their doctor virtually from their home 
rather than physically go to the doctor's office when they're sick. It is believed that the problem is 
even grave for people with physical disability and chronic patients.  
 
Almost 78% of respondents said they seek medical information from internet while they are sick 
confirming previous studies that suggested that the figure was close to 80% for Norway. 
However, people are skeptic about the information on the grounds of credibility of the 
information provider, authenticity of the information and the volume of information available in 
the internet. There is a need for a reliable medical information provider that furnishes to the 
people the most relevant information based on their case when they are sick. Also, many people 
are interested in knowing whether there are people around them that have similar cases at the 
moment when they are sick. About 63% of the respondents want to know whether they are a part 
of a group of people who is having the sickness at the moment or do they stand alone.   
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4.3 The Solution 
Erdusyk is a disease query engine that provides people with epidemiological information and a 
facility for e-consultation with their doctors. The disease query engine is currently available at 
https://www.erdusyk.no and will also be developed as software application for mobile phones 
and tablets. The facility for e-consultation enables people to meet their personal doctor through 
their phones, tablets or computers in the form of e-mails, audio or video interaction. This has the 
possibility of eliminating the physical discomfort and the time consumption during the 
consultation that has been problematic for some people as depicted by the research. With this, 
people who don’t necessarily need to travel to the doctor’s office can consult with their doctor 
from wherever they want through email, audio or video. The disease query engine has symptom 
checker function where people get diagnostic suggestions based on the symptoms they elicit. 
People know the probable disease they might have caught and information about that particular 
disease. The disease suggestions increases the degree of relevance of the information content 
since the patients will look out for the probable diseases diagnosed based on their symptoms. 
However, the most unique feature about the product is that it provides epidemiological 
information of the disease situation. This information contains how many people have elicited 
similar symptoms and disease cases and from which part of the country. It fulfills another need 
of the people that has been verified by the study. This information hopefully helps people to 
decide on the immediate course of action they want to take for the sickness they have got.  
 
4.4 Value proposition 
In addition to the customers, GPs and GP offices are the important members of the value chain. 
The values for the value chain components are stated hereby; 
 
4.4.1 Customers 
Customers, as stated above, will have access to the health information they aspire. The online 
health information will be provided based on their symptoms and thus will be more relevant than 
the ordinary searches. The most unique value is the epidemiological information. Erdusyk 
provides the information about the frequency of incidence of similar cases all around Norway. 
This provides people with much more information so that they can take some immediate 
decisions on their case; from what remedies to take to whether or not to see the doctor right 
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away. Similarly, the value of e-consultation that the survey has articulated does not need 
reiteration. People are spared of the discomfort of traveling, cost of traveling, cost of the time 
wasted in wait for appointment and the wait in queue for the consultations that do not necessarily 
need to be physical.  
  
4.4.2 General Physicians (GP) 
GPs are the gatekeepers for people’s admission into the healthcare system in Norway. People 
usually go to their GPs when they are sick. The use of e-consultation needs participation of 
doctors in the system. Similarly, the infrastructure for the service needs installation of a 
computer device in every GP offices. They are thus an important member of value chain. They 
will receive 10 NOK for every electronic consultation made in excess to their consultation fee. 
The epidemiological information provides GPs with diagnostic decision support system which is 
quite important for doctors. Similarly it also disseminates procedural information among doctors 
which are are of significant value to doctors. Similarly, the chances of disease transmission are 
lowered from patients to doctors in cases of transmittable diseases.  
 
4.4.3 GP Offices 
GP offices are usually group of doctors. The values for GPs are the values for GP offices as well. 
Additionally, this service could mean lower number of people waiting in the lobby. That’s why 
there are low waiting queue management costs and low chances of transmission of diseases 
among the people.  
 
4.4.4 Municipality/Nation 
The installation of box and extraction of epidemiological information could help create disease 
surveillance system and epidemic outbreak detection system so that major epidemic outbreaks 
could be detected timely and preventive measures could be taken. This way even the impact of 
huge epidemics could be mitigated and that would mean lower health expenses for government 






4.5 The Organization 
Erdusyk was created by a research team named ‘Snow’ at Norwegian Center for Integrated care 
and telemedicine (NST). Erdusyk is developed from years of research at the telemedicine 
department at UiT - The Arctic University of Norway(UiT). A spin-off company named Erdusyk 
AS will be formed with the objective of commercializing the product. The organizational 
structure is depicted hereby; 
 
CEO: Dipesh Sigdel is currently a master’s degree student at UiT studying Business Creation 
and Entrepreneurship. He also holds a Bachelors degree in Business Administration with 
specializations in finance and marketing. He is a young guy full of energy for a start-up and is 
looking for a breakthrough in his professional career. Good communicational skills, strategic 
management, marketing management, financial management and business development are some 
of his core competencies. He will handle all the operational tasks for the organization such as 
development and execution of the strategic goals and objectives of Erdusyk AS.  
 
Technical Staffs: They will work on the development, maintenance and support of the technical 
infrastructure required for the operation. Installation of the required software in computer boxes, 
installation support of the box in GP’s local system, continuous maintenance of the box and 
software, update of the software and many other technical works are needed which needs to be 
performed by the technical staffs. One technical staff is hired in the beginning with one more to 
be added on in the later years in response to the scaling rate.  
 
Marketing staffs: Marketing staffs will be hired who will perform all the promotional activities 
of the organization. The commercialization of the product means the need to make people aware 
of the product and its values.  
 
Board of Directors: The Board is critical for providing knowledge and relevant information 
related to technology and market to the management team. The needed market expertise and 
experience within the field of commercialization is also crucial for the CEO and management 





Board of Directors 











Johan Gustav Bellika is a chief researcher at Norwegian Center for Integrated Care and 
Telemedicine (NST). He is also the project leader for the Snow, M3, and Erdusyk development 
projects at NST. He is also a professor at department of Clinical Medicine, Faculty of Health 
Sciences in UiT. He is a highly respected scientist with over 40 publications. Majority of his 
publications are about telemedicine and Health Informatics.  
 
Wenche Poppe has worked with innovation and commercialization of innovative projects 
originating from UiT and UNN since 1998. Currently positioned as vice director at Norinnova 
Technology Transfer, she has been working extensively with development of innovative projects 
in IT and e-health innovations since 2005.   
 
Nils Kolstrup is a GP by profession. He has been in the profession since 1985. He is also a 
medical advisor at Norwegian Center for Integrated Care and Telemedicine. He has a good 
knowledge about the health care system in Norway and can reflect on the project from a doctor’s 














Figure 8: Organizational structure 
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4.6 Market  
Huge portion of the population in Norway uses internet to collect information about many and 
health is not any different. A study by Andreassen et al. (2007) has revealed that almost 74% of 
internet users in Norway seek health information through the internet. The information is also 
verified by the market research conducted for this case where 76% of the respondents have 
confessed so (refer to chapter 3 for more information). Almost 3.8 million people in Norway 
look for medical information in the internet when they are sick. There were 63% of respondents 
willing to know if other people have caught similar diseases, a need fulfilled by epidemiological 
data. If that data is to be followed with the assumption that the responses are unbiased, that 
makes almost 3.15 million people in Norway. An emphatic 77% of respondents are interested in 
a service that allows them to have an electronic-consultation with their GP. That corresponds to 
3.85 million Norwegians. That population includes 3.1 million people (62%) who say they are 
actually willing to pay for that service. 
 
The ultimate target customers are all the people in Norway who seek online health care service. 
However, for a market breakthrough, focusing on a smaller group of customers having larger 
utility for e-consultation was seen as the viable approach. Since the epidemiology and disease 
query engine will only become effectively functional after the appliance boxes (see section 4.7 or 
section 2.1.1 for appliance box) are set up in large number of GP offices, e-consultation needs 
the focus first. The initial target market for this case is the handicapped and chronic patients’ 
group in Tromsø. That is one of the smaller groups known to have huge utility for e-consultation 
service. The data about the number of handicapped and chronic people is quite scattered and 
difficult to assemble. The assimilation of scattered information suggests that the population of 
such people is 15-20% of total population. That is the pilot segment that will be targeted first.  
 
It is believed that the mobile phone penetration in the Norwegian market is almost close to 
100%. Similar percentage of population owns a computer. Regarding technological development 
within the healthcare system, it is found out that 98% of the Norwegian GP uses a computer and 
87% have a disposal to Internet connection (International telecommunication union, 2004). Thus 




4.7 Competitor Analysis 
 
Table 3: comparative analysis of competitors 
 
Comparing the needs of the people and the competitive offerings made, there is no other website 
or an application around the globe that provides the combined service of health information, 
disease query engine and e-consultation. There are some world leaders in medical information 
providers in the competitive scenario such as mayoclinic, webmd and drugs.com but they do not 
offer epidemiological information for the disease query. None of the disease query engine 
provides epidemiological search. The epidemiological information that Erdusyk.no has is 
unprecedented and it is updated in daily basis that makes it quite useful and makes the diagnosis 
more meaningful. Also, there is no service that provides e-consultation in the form of text, audio 
and video with the personal GP. Some of the GP offices have telephone query facility which is 
not too appreciated by doctors because they make lot less money and a lot of patients call 
making their work even cumbersome. Some of the websites provide the facility only in the form 
of text. The consultation that they provide is not with the personal GP that makes it even 



















      
Nettlegevakt.no 
      
NHI.no 
      
Onlinelege.no 
      
Legehandboka.no 
      
Helsenorge.no 
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booking appointments, receiving prescriptions, conducting an e-consultation and having contact 
with the GP office if the GP provides such facilities and has made the information available at 
helsenorge.no. Under helsenorge.no, the government is supposedly trying to build a central 
database called ‘kjernejournal’ that wants to get patient’s health records from GP offices and 
store it outside the GP offices. The healthcare institutions own the records and that new approach 
stores data outside the healthcare institutions. First and foremost, healthcare institutions do not 
want to give away their property. Secondly, the new method needs doctors to store every 
patient’s information in the server per every consultation. Also, storing the data outside the 
health institution is not too safe and it also might need some encryption of data which make it 
impossible to reuse the data for other purposes in the future. Such an approach is also not as safe 
as the Erdusyk’s approach where the data owned by the healthcare institutions are kept by the 
healthcare institutions themselves. It extracts only the necessary data from the health records at 
healthcare institutions for making statistical calculations.  
 
4.8 Business Model 
 
Figure 9:  Business Model Canvas 
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The actual services provided by “Erdsusyk” are e-consultation facility and disease query with 
epidemiological information. A prototype of disease query engine (DQE) has already been 
developed. The DQE and an interface for e-consultation will be installed in minicomputers. The 
minicomputer (also called appliance box) is a type of small personal computers (refer to section 
2.1.1). The boxes will be bought and the software be installed by Erdusyk AS. After the 
installation, they will be provided to those GP offices who agree to set the boxes up in their 
information technology system for the connection. The appliance boxes will be paid for by 
Erdusyk. Once the device is connected to the system, it will automatically start to operate. The 
disease query, e-consultation and epidemiology service becomes instantly available through 
Erdusyk website or mobile application after that (refer to chapter 2. innovation study for details). 
After the device is connected to the system in GP offices, it will extract relevant information 
from GP offices and conduct statistical processing and present the information to the users. The 
patient’s electronic health records in GP offices are properties of the GP offices. The device will 
not extract any personal information of the patients or the GPs. The medical information will be 
anonymous and used for collective data analysis and statistical processing. A contractual 
agreement will be done between Erdusyk AS and GP offices regulating the terms of use of data 
and regarding the protection of privacy of data.   
 
Since the consultation service is provided by doctors and a section of epidemiological 
information is based on data from GP offices, it is imperative to have collaboration with GPs. 
During the market study, doctors weren’t found too willing to provide e-consultation primarily 
due to regulatory obstacles that affect their incentive system to some extent. There are, however, 
ways to work around those hurdles. The epidemiological information, on the other hand, is much 
valuable for doctors. So, they are believed to be willing to allow the setup of those devices in 
their offices in exchange of epidemiological information, the extra income from e-consultation 
and other values discussed in the value proposition section above. 
 
People will have access to Erdusyk through the internet and also will be downloadable as an 
application for phones and tablets. Users will be provided with two options for the product. They 
can have e-consultation with ordinary free accounts or they can buy a premium membership with 
features of e-consultation and free epidemiological information. With free accounts, people pay 
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for doctor’s consultation as well as some extra fee for Erdusyk’s service, use disease query but 
won’t have access to epidemiological information. While with a premium membership (which 
can be monthly, semi-annual or annual), people only pay for doctor’s consultation fee and get all 
other services for free. The e-consultation service will be ready for those GP offices that have the 
device connected in their system. Some income will start to flow from some of the GP offices 
from the second year. The income will be used further to finance the purchase and installment of 
more devices in more GP offices. 
  
4.9 Market Strategy 
The long term objective of Erdusyk is to develop a full-fledged epidemiology and possible e-
consultation from all the GPs and GP offices in Norway. Only then, all the patients can receive 
an effective disease query engine and possibility for e-consultation with their GP. A full-fledged 
epidemiology refers to setting up computer boxes in all the GP offices, hospitals, and 
microbiology labs in Norway. Short term objectives are to set up the computer boxes in all the 
GP offices in Troms and Finnmark County within a year. That way the e-consultation can be 
possible for all the people residing in that area and the DQE can be tested. Also, within that time 
span, all the chronic patients and handicapped people in that area will be able to receive e-
consultation from their doctors. Health issue is so complicated and it is difficult to create a 
demand for a technology like this. It is found that doctors are unwilling to break the conventions 
and patients are afraid of trying new technology. So the usefulness needs to be manifested by 
focusing on smaller group with larger need and then creating demand for others. Handicapped 
and chronic patients have greater need for e-consultation and Erdusyk is going to provide that for 
them in the beginning. 
 
4.9.1 Product 
The product is known as Erdusyk which is a combination of an epidemiological disease query 
engine and a facility for e-consultation. The epidemiology and e-consultation service are 
provided under premium subscription scheme. Here the people pay the subscription fee and get 
the service for free. Or, for people who do not want a premium scheme, e-consultation is 
available as a stand-alone product. People pay for the doctor’s fee and the service charge. The 
disease query engine is available for all for free. Disease query gives information on what 
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disease the person might have caught and epidemiology model on how many other people have 
caught the disease recently and where, and information on what actions other people have taken 
for the cure. The action, here, refers to what percentage of the people consulted their GP and 
what percentage did not. Then, they are offered an option for e-consultation for whosoever might 
want to receive a consultation through computer or a phone.  
  
For the initial target group, the main product is e-consultation. These people have, at times, 
higher utility for e-consultation than any other group. The product is basically the same for the 
initial target group and the ultimate group. The emphasis is more on e-consultation for the initial 
target since they have higher difficulty in movement. However, they also need general medical 
information as everybody else which Erdusyk will provide. The benefits for the people from 
Erdusyk are reduced convenience, reduced wastage of time as well as the epidemiological 
information.   
  
Erdusyk is available as a website and also as an application for mobile phones and tablets. 
People can do the disease query without any identification. For, epidemiology and e-consultation 
however, they will need to set up an account in Erdusyk first. Disease query and the health 
information will be available for free. However, they will need to pay for the epidemiological 
information and e-consultation. 
 
4.9.2 Promotion 
The product will be used by patients and paid by them. The promotional activity is basically 
targeted towards the patients. However, since the computer devices need to be setup in the GP 
offices, promotional activities need to be directed as well towards the GP offices and GPs. 
  
First, the managers at GP offices need to be contacted individually by the company manager. It is 
important to let them know about the benefits of setting up the appliance boxes in GP offices for 
them. The knowledge of epidemiology is much helpful for doctors for diagnostic decision 
making and that benefit should be hyped. Besides the access to epidemiological data, lower 
number of waiting patients in the queue and lower transmission of diseases through or among the 
waiting patients are some of the benefits the GPs and GP offices can have. These benefits need to 
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be communicated comprehensively to them. Similarly, they should also be assured that the 
device for the Erdusyk will not in any way impinge the privacy and integrity of their database. 
Similarly, Erdusyk will present the importance of epidemiological data and its influence on 
diagnostic decision making in health conferences obtaining service of some telemedicine 
personnel from the Snow group. This is a way to make the doctors more aware about what 
Erdusyk is planning to do and make them more acceptable for the installation offers. 
For initial customer target, the e-consultation facility of Erdusyk will be introduced through GPs. 
Handicapped people and several chronic disease patients have unions and interest groups. People 
will be made aware about the availability of such service through promotional campaigns at 
union meetings. Also, a new study reveals that health marketing dollars might be better spent 
targeting the caregivers of the consumer group, rather than marketing to older and handicapped 
group themselves ("Healthcare Marketing and the Internet: To Reach Older Adults, Target 
Caregivers", 2016). As such, the caregivers will also be made aware of the product through 
advertisements through the internet and social media. Caregivers can influence the healthcare 
decisions made by handicapped and chronic patients and thus they should be considered for the 
promotional activities as well. After the initial target has been achieved, the internet, news media 
and social media will be used to promote Erdusyk to the general public. The stories of patients 
receiving the benefits will be shared through newspapers and television and radio. Similarly, 
advertisements will be posted in the most popular health websites such as NHI.no and elite 
health websites in Norway.  
 
4.9.3 Place 
The appliance boxes are bought from a wholesaler supplier and the program is installed in them 
by the technical staff of Erdusyk AS. The appliance boxes are shipped to the GP offices which 
agree to connect the devices in their system. It is so easy that anybody from the GP office can 
plug the box into the system and it will start functioning on its own without anybody even 
noticing any change in their system. The assistance, if needed, will be provided by our technical 
staff. As soon as the box is set up, it becomes able to extract electronic health records (EHR) 
anonymously for the statistical calculation as per the disease query. The epidemiology extracted 
by the device keeps on updating itself with the recording of new EHRs by doctors. There is a 
factor of trust from GPs that plays an important role. They should trust that the appliance box 
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does not impinge the privacy and integrity of their data in any way. Contractual agreement 
between the GP offices and Erdusyk will be done regarding the extraction and use of HER which 
might help alleviate the problem to some extent. As soon as the computer box is plugged in, the 
disease query engine and the e-consultation facility will be available at www.”Erdusyk”.no. It is 
a Norwegian website and people get access to the service through the website. However, it will 
also be developed as a mobile application for those who want to use it in their mobile phones. 
The website is available for access by everyone and the application is downloadable through the 
app store. 
   
4.9.4 Price 
There are few existing online services that provide e-consultation where people enquire doctors 
through texts and doctors reply their queries. They charge 200-260 NOK per enquiry, a 100 
NOK extra for swift reply within a day and 100 NOK extra for private reply. Some of them have 
feature where doctors even write electronic receipt with which patients can buy medicines from 
pharmacies. The medical information is however free of cost and there are a number of websites 
providing that. NHI.no for instance has comprehensive information about almost all the diseases 
and healthy living and many other health aspects. However, nobody has the epidemiological 
information and that is quite valuable. With Erdusyk.no people will have an option to read 
general medical information and symptom search. However, for comprehensive search and 
epidemiological comparison, people need to have a premium membership account at Erdusyk.no. 
People with the premium account are able to fetch epidemiological data and be able to connect to 
the doctor. People can buy a yearly premium account for 200 NOK. A monthly account will cost 
50 NOK and a semi-annual 100 NOK. It will allow them to acquire epidemiological information 
and an option for e-consultation through the account. Every e-consultation will cost equivalent to 
doctor’s fee. For people who do not want to have a premium account, they will have to pay 30 








• Establish Firm with a CEO and three technical staffs. 
• Set up appliance boxes in majority of Gp offices in Tromsø (within the second 
half of the year). 
2017 
• Conduct a pilot test on e-consultation on chronic and handicapped patients in 
Tromsø. 
• Set up computer in GP offices in Troms (within first six months)   
• Set up computer boxes in Gp offices in Finnmark county. (next six months) 
• Make The Disease Query engine and E-consultation available for Troms and 
Finnmark by the end of the year. 
2018 
• Set up computer boxes in Oslo County within the year and recruit one more 
technical staff  
• Broaden the target to include general people in troms and Finnmark for the use of 
e-consultation. (First 6 months) 
• Recruit a marketing staff (second half six months).  
• Set up computer boxes in Akershus county. 
2019  
• Set up boxes in Rogaland and sør-Trøndelag (first 6 months) 
• Make full-fledged product available for the entire population in Norway. 
• Extensive promotion and marketing through health conferences, news media, 
social media and the internet. Also, through endorsement through customers who 
have already used it. 
• Set up an office in Oslo. 
• set up boxes all over Norway within 2019. 
4.10 Milestones 
Some important milestones for next four years are presented hereby; 
 
4.11 Financial Evaluation 
The expansion of Erdusyk’s service market will be done according to the milestones listed above 
and thus the cost of setting up the computer devices and possible number of customers will be 
gradually increasing with the expansion. The computers will first be set up in Tromsø in the first 
year. Both Troms and Finnmark counties will be the targeted the next year moving on to Oslo 
and Akershus the next year. Installation in Rogaland and Sør-Trøndelag and then the entire 
Norway in the fourth year will make the services fully functional. Installation of appliance boxes 
has some values for doctors and thus it is believed that 70% of GP offices will allow the 
installation. There are two revenue sources viz. premium subscription fee and e-consultation. 
Figure 10: Milestones for next 4 years 
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The variable cost for stand-alone e-consultation is the doctor’s fee while there is no significant 
variable cost for the subscription.    
 
The estimation of cost and revenue is based on several assumptions. Observation of overall 
pattern of GP offices, it was seen that there were in average, 4 GPs in each GP office. In average, 
a GP is assigned for 1150 people. Thus, one GP office provides service to about 4600 people. 
The number of GP offices in each county is thus calculated based on the population of that 
county, i.e., dividing the population by 4600. For revenue, stand alone e-consultation will be 
ready for people in Tromsø from the beginning of 2017 since the installation of box is done in 
2016. Each doctors makes about 20-24 consultations per day and about 20% of the consultations 
can be electronic which equals to about 4 consultations per day (based on interview with a 
doctor, refer to section 3.2.3). The initial target is handicapped and chronic people that comprises 
of 18% of population (refer to section 3.2.1). It is assumed that about 50% of the target group 
will be willing to use e-consultation for the cases that can be electronic. So, for one doctor, there 
can be 4*0.18*0.5 = 0.36 electronic consultations per day. That value multiplied by number of 
doctors in Tromsø and number of days in a quarter of a year will yield the number of quarterly e-
consultations. Similarly, the installation of box proceeds to other counties and the respective e-
consultations follow the following half year in that county. Similarly, it is assumed that at least 
70% of the GP offices will agree to set up the boxes. The setup of 70% of the boxes will be 
finished in year 2019. And, from the start of second half of 2019, the sale of subscription starts. 
The sales forecast is very difficult to make and thus the financial calculations will deal with mere 
assumptions. However, a scenario method is used in cash flow statement so that the cash flow 
will be known for 10% higher or lower sales than assumed.  
 
The assumption is that people would first like to try only the monthly and semi-annual packages 
about 1.25% and 0.1% of people from the counties where the boxes’ set up is completed. It is not 
known for sure how many people would subscribe for the packages, so the values are mere 
assumption. There will be a gradual increase in sales in the following year when the set up will 
be completed in all the counties in Norway. However, the sales of monthly subscription will 
decrease with many people favoring a semi-annual or an annual one. About 0.1% of population 
is estimated to subscribe the annual subscription for the first time in 2020. The number of 
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subscription is believed to increase by additional 0.1% every quarter for the year for annual and 
0.2% for semi-annual and saturate at the end of the year. The increase in subscription revenue 
will decrease the stand-alone e-consultation revenue. Revenue from stand-alone e-consultation is 
much higher but the margin is much low as a huge amount of revenue (approx. 82%) is paid out 
to the doctors for the consultation. The revenue tables and chart are available in the appendix 6, 7 
and 8.  
 
Table 4: Income statement 
Income Statement (All figures in thousands) 
Particulars 2016 2017 2018 2019 2020 
Revenues      
Number of e-consultation sales  0 4.08 36.67 113.78 353.64 
E-consultation revenue (a) 0 694 6,233 19,342 60,119 
number of subscription sales  0 0 0 10.39 102.23 
subscription revenue (b) 0 0 0 668 12,260 
Total revenues (a+b) 0 694 6,233 20,134 72,835 
Cost of goods sold         
 
E-consultation  0 569 5,111 15,861 49,297 
subscription  0 0 0 24 296 
Total Cost of goods sold 0 569 5,111 15,884  49,594 
NET Contribution         
 
E-consultation 0 125 1,122 3,482 10,821 
Subscription 0 0 0 644 11,964 
A. Sum NET contribution  0 125 1,122 4,125 22,785 
COST OF OPERATIONS         
 
B. Salary & Personnel cost 1,047 2,238 3,613 4,055 4,160 
C. Other Operating Costs 124 309 379 924 831 
D. TOTAL OPERATING 
COSTS  
1171 2547 3992 4979 4990 
E. EBITDA (E=A-D) -1,171 -2,422 -2,870 -854 17,795 
Depreciation -6 -40 -239 -652 -989 
F. NET INCOME -1,177 -2,462 -3,110 -1,506 12,100 
 
The yearly income statement looks like above. It is estimated that the computer will cost 6,500 
NOK and last for 5 years. Using straight line depreciation method the estimated depreciation was 
1,300 NOK. For cutting up the cost, the office space will be used at the incubation center. Only 
on the 4th year, a proper office space will be rented. 5% of last year’s net profit will be invested 
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in parent company for research and development from year 6. Similarly, marketing costs is 
allocated at 1.5% of last year’s net income. Quarterly net income is available in appendix 9. 
Most of the expenses and revenues are supposedly paid and collected within the same quarter as 
incurred. So, the cash flow is quite similar to the income statement.  
 
Cash Flow, Firm value and the Capital Requirement 
Quarterly cash flows for the firm without capital funding under normal scenario are shown 
below;  
 
Figure 11: Quarterly cash flow for next five years under normal case scenario 
 
As seen in the figure above, the cash flows for next three years are negative under the normal 
case scenario. Significant amount of cash is invested in the installation of appliance boxes and 
paying the human resource. It denotes a need for capital at the inception. The cash flow trend 
follows a much similar pattern for scenarios with both 10% higher and lower sales case than 
assumed. Total cash deficit results to about 13.9 million till the end of the 3
rd
 year. The value for 
lower sales scenario is 14.5 million. Based on the deficit, it is believed that an investment capital 
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scenarios. We expect to get 4 million NOK from Innovation Norway. There is a need of capital 
financing of 11 million NOK. Erdusyk is looking for the investment in exchange of 30% 
ownership of the firm.   
 
The value of the firm is calculated through Net present Value method. The summation of 
discounted present value of all future cash flows is the net present value. The discounting rate is 
calculated to be around 18%. The return on government 10 year bonds is used as risk free rate 
and the market risk premium is about 5% (Fernandez, P., et al. 2014). Beta value is the measure 
of systematic risk of a firm. Beta value of 1 denotes that a company’s systematic risk is equal to 
that of the market. A start up is always a risky business so it is believed that a Beta value of 3 is 
reasonable in this case. Using Capital Asset Pricing Model, the discounting rate is evaluated. 
This way the net present value of firm is calculated to be approximately 46.06 million NOK.  
See appendix 11 for the details. 
 
4.12 Critical Risks 
The probable risks with their probability and methods to prevent or eliminate the risks are 
presented hereby; 
 
1. Lack of adoption of the product by Market: ‘moderate probability and huge impact’ 
 
The market study has gathered enough evidence that people want to use such service. 
However, there might still be a bit of probability that people will not adopt the product due to 
poor understanding of the product value. That being the case, product will be discarded and 
that will have massive impact on the firm. This risk is taken care of by making people aware 
about their pains and how they can be eliminated without jeopardizing their well-being. 
Promotion of the service through GPs and through campaigns at handicapped and chronic 
patient’s union meetings is the most viable option. Once, the pilot group uses the product, paid 
endorsement through the initial users will be done to make other people aware about the 
adoption.  




The product and the technology do not impinge the regulatory statutes in any way. There could 
be, in least possible cases, some changes in regulations in the future that might affect the way 
the project moves further. The use of epidemiology as disease outbreak detection system and 
the thousands of dollars that the information can save for the government will be let known to 
government. Similarly, the patient’s health records are the properties of GP offices and they 
have exclusive right over the data. The software in the appliance box is created so that it can 
only extract that part of health record data that does that does not include the personal 
information of any individual. The information is purely epidemiological and impersonal.   
3. Reluctance of some GPs or GP offices to install the box: ‘moderate probability and high 
impact’ 
 
The value of diagnostic decision support system which can be created from the 
epidemiological data for the doctors needs to be well relayed. The need to install computer box 
for the epidemiological data must be emphasized. Also, doctors receive extra bit of allowance 
for e-consultation service. Similarly, the exclusive right of their data is preserved. The value 
for doctors is quite significant and that should be let known.   
4. Competitive values: “moderate probability and moderate impact’ 
 
There could be competing solutions offered to people. Investment in R&D and continuous 
improvement based on the people’s current and emerging pains and feedbacks will be done.   
 
4.13 Exit Strategy 
After the full fledged service is developed in the fourth year, the returns are maximized and the 
market will be matured. The market value of Erdusyk will be the highest at the point. It is 
believed that many companies will be interested to buy Erdusyk. Erdusyk will most probably be 
developed as an indispensable part of health care service system in Norway. The multitude of 
benefits it can provide to people, doctors and the state will warrant its adoption in the health care 
system by government. The government of Norway is taking initiatives to store the health 
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records of all the patients in a single server for creation of epidemiology. ‘Kjernejournal’ is the 
government’s initiative for that cause. However, it raises concerns of sensitive data and privacy 
issue of patients. The EHRs are private information of patients and property of GP offices. GPs 
are not willing to provide their patient’s private information. The security of data stored in such 
manner is one huge concern as such servers are prone to hacking. Similarly, the data is accessible 
to people who create the central reservoir of data. Also, the data need to be encrypted in a way 
that makes it difficult for the data to be reused. The infrastructure that the appliance box has 
solves all the issue by putting the patient’s records at GP offices itself and extracting only the 
epidemiological information from the GP office’s records. All the problems above is solved by 
this method. It has all the infrastructures that fulfill the need the government of Norway has been 
trying to fulfill. It is believed it is something that the government of Norway will want to 
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Appendix 1: The Questionnaire  
Erdusyk.no 
 
Thank you very much for your willingness to participate in this study. The purpose of this study 
is to discover people’s perception about the current general medical service in Norway in an 
attempt to devise a better service that will be valuable to both the patients and the doctors. This 
study attempts to generate insights about the feasibility of using telemedicine technology in GP 
consultation and creation of disease query engine. The study is also a vital part of a master’s 
thesis leading to the creation of a business plan. Your responses will be anonymous and your 
participation is voluntary. Please tick the favorable responses from below. Thank you for your 
cooperation. 
 
1. What is your age?  
Mark only one oval. 
o 18 to 24  
o 25 to 34  
o 35 to 44  
o 45 to 54  
o 55 to 64  
o 65 to 74  
o 75 or older  
2. What is your gender?  
Mark only one oval. 
o Female  
o Male  
3. What part of the country do you live in?  
Mark only one oval. 
o City  
o Suburban area  
o Countryside  
87 
 
4. About how many times a year do you visit your personal doctor to get care for 
yourself?  
Mark only one oval. 
o None  
o 1  
o 2  
o 3  
o 4  
o 5 to 9  
o 10 or more  
5. How far is the GP (personal doctor)'s office from where you live?  
1 mile = 1.6 kilometer (approximately) 
Mark only one oval. 
o less than a mile  
o 1-2 miles  
o 2-5 miles  
o 5-10 miles  
o more than 10 miles  
6. How satisfied are you with the overall medical system in Norway?  
Mark only one oval. 
o Extremely satisfied  
o Very satisfied  
o Somewhat satisfied  
o Not so satisfied  
o Not at all satisfied  
7. What are the things you find most inconvenient when visiting a doctor?  
(you can select more than one options) 
Check all that apply. 
o late appointment date  
o long queue  
o doctor's fee  
o clinic location  
o parking difficulty  
o physical discomfort (while sick and waiting in a queue)  
o time consumption (a lot of your time is wasted in the process)  
o Other:  
8. What is your perception about having to travel to doctor's office when you're ill?  
Mark only one oval. 
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o HIghly uncomfortable  
o Uncomfortable  
o Comfortable  
9. Would you prefer to consult your doctor virtually from your home rather than 
physically go to the doctor's office when you're sick?  
Mark only one oval. 
o Yes  
o No  
10. Do you seek medical information from the internet while you're sick?  
Mark only one oval. 
o Yes  
o No  
11. If you do, is there a particular website or a mobile application that you use?  
Mark only one oval. 
o No  
o Yes  
If yes, please specify the name of the website/application  
12. About how much money do you spend on obtaining online medical information in a 
year?  
Mark only one oval. 
o 0  
o 0-50 NOK  
o 50-100 NOK  
o 100-500 NOK  
o 500 and above  
13. How satisfied are you with the medical services and information available online?  
Mark only one oval. 
o Extremely satisfied  
o Very satisfied  
o Somewhat satisfied  
o Not so satisfied  
o Not at all satisfied  
14. If not satisfied, is there any particular feature that you are dissatisfied with?  
(multiple selection possible) 
Check all that apply. 
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o Credibility of the information provider  
o Price  
o privacy issues  
o authenticity of the information  
o quantity of content present on the pages and apps  
o too large number of search results  
o large part of information is irrelevant  
o Other:  
15. When you/your family member is sick, would you be interested in knowing whether 
or not other people have similar problems during that period?  
Mark only one oval. 
o Yes  
o No  
16. Would you be interested in a service that allows you to have a consultation with your 
personal doctor online (in text, audio or video forms through your phone or a computer)?  
Mark only one oval. 
o Yes  
o No  
17. Would you be willing to pay to be able to use such service?  
Mark only one oval. 
o Yes  
o No  
18. If yes, how much would you be willing to pay for such service per consultation 
(meeting with the doctor) ?  
Mark only one oval. 
o less than 50 NOK  
o 50 -100 NOK  
o 100 - 200 NOK  









Appendix 2. Responses from the Questionnaire Survey  
 
1. What is your age? 
18 to 24 25 to 34 35 to 44 45 to 54 55 to 64 65 to 74 75 or older 
34 68 23 14 5 0 1 
23.40% 46.90% 15.90% 9.70% 3.40% 0% 0.70% 
 





3. What part of the country do you live in? 
City Suburban area Countryside 
84 14 11 
57.90% 9.70% 7.60% 
 
4. About how many times a year do you visit your personal doctor to get care for 
yourself? 
None 1 2 3 4 5 to 9 10 or more 
29 55 33 15 7 4 2 
20% 37.90% 22.80% 10.30% 4.80% 2.80% 1.40% 
 
5. How far is the GP (personal doctor)'s office from where you live? 
less than a 
mile 1-2 miles 2-5 miles 5-10 miles 
more than 
10 miles 
37 28 30 6 8 
33.90% 25.70% 27.50% 5.50% 7.30% 
 












11 74 45 12 0 
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7.70% 52.10% 31.70% 8.50% 0% 
 
7. What are the things you find most inconvenient when visiting a doctor?  
late appointment date 57 
long queue 46 
doctor's fee 31 
clinic location 3 
parking difficulty 8 
physical discomfort (while sick and waiting in a queue) 9 
time consumption (a lot of your time is wasted in the process) 49 
Other 17 
 
8. What is your perception about having to travel to doctor's office when you're ill? 
HIghly uncomfortable Uncomfortable Comfortable 
10 58 40 
9.20% 53.20% 36.70% 
 
9. Would you prefer to consult your doctor virtually from your home rather than 
physically go to the doctor's office when you're sick? 
Yes 51 46.40% 
No 59 53.60% 
 
10. Do you seek medical information from the internet while you're sick? 
Yes 110 75.90% 
No 35 24.10% 
 
11. If you do, is there a particular website or a mobile application that you use? 
No 103 76.30% 
Yes 32 23.70% 
 

















I just google it, and offcourse look for credible sources. 
I just google after the information I need 
http://www.nhs.uk/pages/home.aspx 
 
12. About how much money do you spend on obtaining online medical information in a 
year? 
0 135 93.10% 
0-50 NOK 3 2.10% 
50-100 NOK 3 2.10% 
100-500 NOK 3 2.10% 
500 and above 1 0.70% 
 
13. How satisfied are you with the medical services and information available online? 
Extremely satisfied 5 3.70% 
Very satisfied 20 14.70% 
Somewhat satisfied 84 61.80% 
Not so satisfied 22 16.20% 
Not at all satisfied 5 3.70% 
 
14. If not satisfied, is there any particular feature that are you dissatisfied with? 
Credibility of the information provider 63 70% 
Price 3 3.30% 
privacy issues 3 3.30% 
authenticity of the information 41 45.60% 
quantity of content present on the pages 
and apps 
11 12.20% 
too large number of search results 12 13.30% 
large part of information is irrelevant 33 36.70% 
Other 10 11.10% 
 
15. When you/your family member is sick, would you be interested in knowing whether 




Yes 29 63% 
No 17 37% 
 
16. Would you be interested in a service that allows you to have a consultation with your 
personal doctor online (in text, audio or video forms through your phone or a 
computer)? 
Yes 112 77.20% 
No 33 22.80% 
 
17. Would you be willing to pay to be able to use such service? 
Yes 89 61.80% 
No 55 38.20% 
 
18. If yes, how much would you be willing to pay for such service per consultation 
(meeting with the doctor)? 
less than 50 NOK 19 17.80% 
50 -100 NOK 27 25.20% 
100 - 200 NOK 19 17.80% 
200 NOK or more 12 11.20% 
 
 
Appendix 3: Baye’s Theorem 
Bayes’ theorem describes the probability of an event, based on conditions that might be related 
to the event. Bayes' theorem is stated mathematically as the following equation: 
 
where A and B are events and P(B) ≠ 0. 
P(A) and P(B) are the probabilities of observing A and B without regard to each other. 
P(A | B), a conditional probability, is the probability of observing event A given that B is true. 




Appendix 4: Early Technology Adoption Cycle 















Appendix 5: Moore (2014)’s Revised Technology Adoption Cycle 
Moore (2014) revised the old technology adoption cycle and depicted the gap between the early 







Appendix 6: Revenue Table for E-consultation 
Here, number of e-consultation = no of GP offices*percentage of appliance box installed GP 
offices*number of feasible e-consultations per day*percentage of people using e-














Appendix 7: Revenue Table for Subscription 
The epidemiology will only have some value from 2019, so the subscription sale will start from 
the 3
rd
 quarter of 2019. It is believed that about 70% of GP offices will accept to install the 








premium account subscription (% of 





  annual semi-annual monthly total 
NOK (in 
thousands) 
19-Q1 0 0% 0% 0% 0% 0 
19-Q2 0 0% 0% 0% 0% 0 
19-Q3 1,347 0% 0.1% 0.25% 0.35% 303 
19-Q4 1,620 0% 0.1% 0.25% 0.35% 365 
20-Q1 2,495 0.1% 0.1% 0.25% 0.45% 1,060 
20-Q2 3,500 0.20% 0.20% 0.20% 0.60% 2,450 
20-Q3 3,500 0.3% 0.4% 0.20% 0.90% 3,850 












16-Q3 0.00 0 
16-Q4 0.00 0 
17-Q1 0.2646 45 
17-Q2 0.5292 90 
17-Q3 1.02 174 
17-Q4 2.268 386 
18-Q1 4.73 803 
18-Q2 5.67 964 
18-Q3 10.58 1,799 
18-Q4 15.69 2,667 
19-Q1 20.22 3,438 
19-Q2 24.57 4,177 
19-Q3 31.19 5,301 
19-Q4 37.80 6,426 
20-Q1 71.40 12,138 
20-Q2 100.80 17,136 
20-Q3 90.72 15,422 
20-Q4 90.72 15,422 
96 
 





Appendix 9: Quarterly Net income 
Time (Quarterly) 









































































net income (in thousands NOK) 
-585 -585 -633 -729 -585 -543 
-1151 -1333 -1106 
-935 





-585 -585 -635 -732 -591 -557 




















cash flow (10% 









Appendix 11: Value of Firm 
Valuation of the business "in thousands NOK" 
    
year expected cash flow 
present value of the cash flow 
(as of Jan 2016) 
 2016 12,831 10874 
 2017 -2,398 -1722 
 2018 -3,824 -2327 
 2019 -2,806 -1447 
 2020 14,000 6120 
 cash flows after 2019 valued at 
















 expected annual average cash 
flow after 2019 20,000   
 
    expected rate of return 18% 
  
    expected rate of return = risk free rate (3%)+rmarket risk premium(5%)*Beta(3)= 18% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
